Dengue risk assessment by van Dodewaard, Caitlin A.
 
 
Dengue Risk Assessment 
by 
Caitlin A. van Dodewaard 
May 2015 
 
Director of Thesis:  Stephanie L. Richards 
Major Department:  Health Education and Promotion 
Abstract 
 Dengue fever is the most prevalent vector borne disease in the world with over 3.6 billion 
people at risk and one billion new infections (including one million deaths) recorded annually. 
Risk assessments showing the impact of travel on the importation of dengue virus (DENV) are 
essential to understand the role of human travel in the spread of this mosquito-borne pathogen 
for which humans are the primary reservoir. Consequently, we calculated the exposure risk of 
United States (US) citizens traveling into Pan American countries where dengue (DEN) fever is 
endemic. The number of DEN cases in 51 Pan American countries was compared to the 
population of the same countries from 2001-2012 as a measure of exposure risk. Travel statistics 
(i.e. US travelers visiting the 51 Pan American countries) were analyzed and categorized by 
geographical region (i.e. North America, Central America, Andean, Southern Cone, Hispanic 
Caribbean and English, French and Dutch Caribbean). Travel patterns for US citizens were 
compared with subsequent DEN infections for each region visited. We show that US travelers 
visiting the Dominican Republic exhibited the highest number of imported DEN infections for 
the period of study. The Pan American country with the most DEN cases in its residents was 
Brazil (> 1 million reported cases in 2010). The numbers of DEN cases in Pan America 
 
 
continues to rise as does international travel and the geographic range of potential DENV 
vectors. Hence, in order for DENV risk assessments to improve, we must analyze possible routes 
of entry for this pathogen. There is also an increased risk of introducing new DENV serotypes 
into naïve human populations. Regions where all four DENV serotypes are prevalent are at the 
highest risk for DHF and DSS. Underreporting and misdiagnosis remains an issue for calculating 
DENV transmission risk and this is discussed. In the second part of this study, commercially 
available blood was analyzed for life table characteristics and vector competence. Commercially 
available blood can be used as an alternative to live animals to maintain mosquito colonies and 
deliver infectious blood meals during research studies. However, the extent to which artificially 
delivered blood sources affect mosquito life table characteristics of Aedes albopictus and vector 
competence for dengue virus (DENV) is unknown. Consequently, we analyzed the extent to 
which two blood sources affected life table characteristics (i.e. fecundity, fertility, hatch rate, 
adult survival) and vector competence (infection, dissemination, transmission) of Ae. albopictus 
for DENV. Two types of blood (N = 40 mosquitoes/group) were tested at two extrinsic 
incubation temperatures for DENV-infected and –uninfected mosquitoes as follows:  1) 
defibrinated, 27°C; 2) citrate, 27°C; 3) defibrinated, 30°C; 4) citrate, 30°C. Fully engorged 
mosquitoes were transferred to individual cages containing an oviposition cup and substrate. The 
presence of eggs was observed daily and, if eggs were observed, the substrate was removed and 
the number of eggs was counted (fecundity) for each female. Eggs were allowed to hatch and 
larvae were counted (fertility) for each female. At 14 and 21 days post feeding, 15 mosquitoes 
were taken from each group and tested for DENV in bodies (infection), legs (dissemination), and 
saliva (transmission). Mosquitoes fed DENV-infected defibrinated blood showed significantly 
higher DENV body titer (P = 0.034) and fecundity (P = 0.032), as well as faster hatch time (P = 
 
 
0.039) compared to mosquitoes fed DENV-infected citrated blood. Temperatures tested here did 
not (P > 0.05) affect any factor measured. No differences were observed in DENV leg titers 
between treatments. DENV transmission was observed in all groups 14 days post infection and 
was observed in all but the 30°C defibrinated blood group at the 21 day post infection time point. 
Infected mosquitoes showed higher fecundity than uninfected mosquitoes (P = 0.001); however, 
fertility was lower in infected compared to uninfected mosquitoes (P = 0.001). Eggs of DENV-
infected mosquitoes hatched faster than the uninfected groups (P = 0.005). We expect the 
findings of this study to improve methods for mosquito colony propagation and inform research 
using artificial blood delivery methods to assess vector competence.  
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Chapter 1 – Introduction and Purpose 
Vector-borne diseases account for 17% of the burden caused by all infectious diseases 
globally, with one billion new infections (including one million deaths) recorded annually 
(World Health Organization [WHO, 2014]). Historically, diseases such as dengue (DEN), 
malaria, yellow fever, filariasis, plague, louse-borne typhus and other vector-borne diseases were 
responsible for more human disease and death between the 17th and 20th centuries than all other 
causes combined (Gubler, 1998). Dengue is the most prevalent vector borne human illness 
(Durbin, 2011, Ross 2010) and there were > 2.5 billion people at risk for DEN infection in 2002 
(Gubler, 2002) (Figure 1). In recent years, the number of “at risk” people has increased to ca. 3.6 
billion (Halstead, 2007; Tolle, 2009; Meltzer and Schwartz, 2009; Halstead, 2013). As of 2002, 
50-100 million new DEN infections were reported each year, including ca. 500,000 severe 
cases/year (Holmes and Twiddy, 2002; Ligon, 2004) and ≥ 21,000 deaths/year (Holmes and 
Twiddy, 2002; Halstead, 2007; Durbin, 2011; Pye, 2012). However, recent studies show 390-400 
million DEN cases/year (Bhatt, 2013; Cross, 2013; Yacoub and Wills, 2014). Globalization and 
climate change (e.g. temperature increase) may facilitate the increased geographic range of 
vectors that transmit dengue virus (DENV; Flaviviridae: Flavivirus), the pathogen that causes 
DEN (Gratz, 1999; Gubler, 2002; Holmes and Twiddy, 2002; Pye, 2012; Tantawichien, 2012).  
Dengue virus is transmitted by mosquitoes (primarily Aedes aegypti L. and Ae. albopictus 
(Skuse) to humans (epidemic cycle) and primates (sylvatic cycle) (Weaver, 2010; Holmes and 
Twiddy, 2002). Dengue virus has four distinct serotypes (DENV-1, DENV-2, DENV-3, DENV-
4) (Gubler, 2002; Simmons 2012) and multiple genotypes, named by geographical location 
(Costa, 2011). Most people infected with only one serotype do not experience symptoms and 
lifelong immunity to that serotype is achieved (Mangold and Reynolds, 2013; WHO, 2014); 
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however, infection with multiple serotypes may lead to severe DEN [i.e. dengue hemorrhagic 
fever (DHF), dengue shock syndrome (DSS)] (Holmes and Twiddy, 2002; Durbin, 2011; 
Whitehorn and Farrar, 2011). Severe DEN is most common when secondary infection with a 
different serotype occurs (Yacoub and Wills, 2014) and severe symptoms manifest themselves 
whenever the viral load is in decline (Guzman et al., 2000). There is temporary immunity (two to 
three months) to all serotypes after initial infection with one serotype (Halstead, 2007; Rothman, 
2013; WHO, 2014). There are no vaccines or antiviral treatments available to protect people 
from DENV (Meltzer and Schwartz, 2009; Yacoub and Wills, 2014), hence vector control is 
essential (Durbin, 2011; Dick, 2012).  
In the Americas, outbreaks of DEN occur in an endemo-epidemic (i.e. the virus is 
endemic but occasionally becomes epidemic) pattern with outbreaks every three to five years 
(Dick, 2012). The circulation of multiple serotypes commonly causes severe epidemics (Gubler, 
2002; Ross, 2010) and this phenomenon has continued to increase (Lorono-Pino et al., 1999, 
Gubler, 2004; Guzman and Harris, 2015). Outbreaks of DEN have been well documented since 
the early 1950s and are increasing, causing economic burdens and proving that preventative 
vector control measures should be taken (Holmes and Twiddy, 2002; Gubler, 2002). Since the 
late 1970s, DENV has become endemic in the Americas, resulting in millions of cases and 
thousands of deaths (Gubler, 1989). Millions of dollars are spent annually on vector control to 
prevent and control vector borne disease in the US and, despite this, revenue has been lost due to 
stagnating tourism and decreased workforces (Knudsen and Slooff, 1992). 
Dengue emergence/reemergence is especially concerning in areas with competent vectors 
(Richards et al., 2012). A better understanding of DENV-vector interactions will enhance risk 
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assessments of DEN expansion. Previous studies have explored the impact of DENV on life 
table characteristics (i.e. fertility, fecundity, lifespan, hatch time, etc.) in Aedes aegypti 
(primarily subtropical/tropical) (Sim and Dimopoulos, 2010; Carrington et al., 2013); however, 
little research has been conducted using Ae. albopictus (primarily temperate regions), another 
efficient vector of DENV. Research on factors influencing the ability of Ae. albopictus to 
transmit DENV (i.e. vector competence) will improve predictions for the risk of DEN expansion, 
hence mitigating outbreaks. The establishment of Ae. albopictus in previously uninfested regions 
shows that few areas with ecological conditions suitable for the vector’s survival are secure from 
its introduction and establishment (Gratz, 1999). Durbin (2012) suggests that mapping historical 
data on traveler-imported DEN cases may improve risk assessments. Prevention and control of 
DF and DHF is urgent due to the increasing geographic distribution of vectors and disease 
incidence over the past 20 years (Monath, 1994). 
The increase in global travel (WTO, 2012) coupled with the geographic expansion of 
DENV and one of its primary vectors, Ae. albopictus, is the primary focus of this study. 
Consequently, we aim to:  1) Determine how human travel between Pan American countries and 
the US affects the spread of DENV, and 2) Assess the extent to which different blood sources 
used in laboratory vector competence studies impact life table characteristics and vector 
competence of Ae. albopictus.  
 
 
Chapter 2 – Literature Review 
History of dengue in the Americas 
There is controversy over where DENV originated. The earliest record was found in a 
Chinese medical encyclopedia in 992 A.D. (Gubler, 1998). An African origin of the virus was 
suggested by Gaunt et al. (2001) because of the number of other mosquito-borne flaviviruses that 
originally circulated exclusively in Africa. Aedes aegypti also likely originated in Africa 
(Holmes and Twiddy, 2002). However, the same study discusses that all four DENV serotypes 
have been documented in monkeys and humans from Asia. The first DEN-like epidemics were 
reported in 1635 in Martinique and Guadeloupe and in Panama in 1699; however, due to the lack 
of epidemiological knowledge at the time, it is uncertain whether the diagnoses were correct 
(Dick, 2012). By the 1700s, a disease resembling DEN caused epidemics in Asia and the 
Americas. The first well documented outbreak of DHF occurred in Manila, Philippines in 1953-
54, followed by an outbreak in Bangkok, Thailand in 1958 (Holmes and Twiddy, 2002). 
During the 18th-20th centuries, DEN outbreaks occurred in coastal cities of the Caribbean, 
North, Central, and South America, and were related to commercial shipping activities (Gubler, 
2002; Guzman, 2003). After a yellow fever epidemic in Rio de Janeiro, Brazil in 1928 and the 
discovery of jungle yellow fever in 1932, scientists realized that the eradication of Ae. aegypti, 
the primary vector of DENV in tropical regions, could protect people from yellow fever and 
DEN (Gubler, 1998; Gratz, 1999; Dick, 2012). Dengue research started in 1943 when DENV 
was isolated for the first time (Severo, 1955). Movement of military troops facilitated DENV 
spread during World War II (WWII) (Ligon, 2004; Tavodova, 2012), i.e. troops became infected 
while deployed in Southeast Asia and returned home to the Americas (Ligon, 2004).  
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After WWII, tropical urbanization and international trade (WHO, 1971) increased. 
Populations of Ae. aegypti and Ae. albopictus spread throughout both hemispheres, increasing 
abundance and ranges of the vectors (Gubler, 2002; Holmes and Twiddy, 2002; Weaver, 2010). 
Most medical diagnoses were based on symptoms, while serology was used to confirm the 
infection for research (not treatment) purposes (Dick, 2012). The government of Brazil 
collaborated with the Rockefeller Foundation of the US to eliminate Ae. aegypti from Brazil 
(Severo, 1955). Other countries followed, including Bolivia, Colombia, Ecuador, Paraguay, and 
Peru (Dick, 2012). Abandoned water-holding containers were destroyed, pesticide fumigation 
was performed and mosquito surveillance increased to ensure Ae. aegypti populations did not 
recolonize treated areas (Dick, 2012). With the advent of dichlorodiphenyltrichloroethane 
(DDT), it was relatively easy for mosquito control personnel to suppress vector populations 
(PAHO, 1947). By 1962, 18 continental countries and many Caribbean islands had eradicated 
Ae. aegypti (Gratz, 1996; PAHO, 1997; Gratz, 1999). However, over the next 10 years, only 
three more countries eradicated Ae. aegypti as the program deteriorated due to the loss of 
political interest, lack of support from the health sector, and insufficient community participation 
(Gubler, 2002; Ross, 2010). Surveillance and control declined, allowing small Ae. aegypti re-
infestations to occur (Ross, 2010; Dick, 2012). Rapidly growing urban centers, expansion of 
international and domestic travel, and insufficient environmental sanitation favored re-infestation 
by Ae. aegypti (PAHO, 1997; Gubler 1998; Gratz, 1999; Gubler, 2002; Ross, 2010). In < 20 
years, the American tropics and the Pacific islands went from not having DEN to having a severe 
DEN problem by 1998 (Gubler, 1998). In Asia, proper mosquito control had never been 
achieved and severe forms of DEN emerged after WWII (Gubler, 1998).  
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Before 1970, only nine countries had experienced epidemics of DHF; however, by 1996, 
that number had increased to 102 countries (Gubler, 2002; Dorji, 2009). Global numbers of DEN 
cases increased during the 1970s-1980s and continued to increase in subsequent years (Gubler, 
1998; Gratz, 1999; Gubler, 2002). In 1977, DENV-1 was detected for the first time in Cuba and 
serological surveys showed that more than 44% of humans were infected (Guzman et al., 2000; 
Halstead, 2007). By 1981, nearly all (98%) DHF and DSS cases in children and adults were 
associated with infection by a second DENV serotype (Diaz, 1988; Rothman, 2013). In 1981, 
Cuba had an outbreak with 344,203 DEN cases and 10,312 DHF cases, including 158 deaths 
(Kouri, 1981, Gratz, 1999). The first case report of infections with multiple DENV serotypes 
occurred in 1982 in Puerto Rico (Gubler, 1985). In 1999, infection with three serotypes was 
found in two patients from Indonesia and one from Mexico (Chinnawirotpisan, 2008). From 
2000-2010, all four DENV serotypes were found in the Americas, causing the highest record of 
cases seen to date (Dick, 2012). Ecuador had 22,937 cases in 2000 with both DENV-2 and 
DENV-3 circulating. In Paraguay, approximately 25,000 cases of DENV-1 were reported in 
2000 (PAHO, 2010). Peru had its worst outbreak in 2001 with 23,329 cases when all four 
serotypes were documented (Vargas, 2005). In 2002, there was a record number of ca. one 
million cases throughout Pan America (Dick, 2012) and Brazil accounted for over 75% of these 
cases (Nogueira, 2005). Costa Rica experienced 35,000 cases in 2005 (Gonzalez, 2007; Dick, 
2012). Paraguay saw a mortality rate of 11.5% in 2006 with over 28,000 cases reported (Dick, 
2012). In 2007, DENV-1, DENV-2 and DENV-3 circulated through Brazil causing 559,954 
DEN cases, followed by 734,384 cases in 2008 (Saude, 2007; Saude, 2008). Bolivia experienced 
an outbreak with more than 84,000 cases and a mortality rate of 12.6% in 2009 (PAHO, 2010). 
DENV-1 caused more than 26,000 cases in Argentina in 2009. Over 250,000 cases were reported 
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in Mexico in 2009 and Nicaragua had an outbreak of 17,140 cases in the same year (Dick, 2012). 
Another Pan American outbreak occurred in 2010 with 1.7 million cases and 1,855 deaths. All 
36 patients experiencing DHF in Puerto Rico in 2010 died (PAHO, 2010). 
Global Burden of DENV 
Dengue virus is endemic in many tropical and sub-tropical regions and is a leading cause 
of post-travel fever (Wilder-Smith, 2007). The risk of DEN is thought to be as high as malaria 
and higher than typhoid or hepatitis A (Wilder-Smith, 2007). With nearly half the world’s 
population living in DENV-endemic regions, most pediatric hospitalizations in these regions are 
due to DEN (Tolle, 2009; WHO, 2005). To determine the global burden and impact on morbidity 
and mortality of a disease on a population, the World Bank developed the ‘disability-adjusted 
life years’ (DALYs) index, which defines the impact of the morbidity and mortality of a disease 
on the population (Murray and Lopez, 1996; Meltzer, et al., 1998; Gubler, 2002). Dengue costs 
hundreds of thousands of DALYs at 427 DALYs/million population (Gonzalez, 2011). In the 
US, each person hospitalized from DEN accumulates ca. $17,803 in medical costs and less 
severe cases cost ca. $1,610. A study reports the economic cost of DEN cases in the Philippines 
in 2012 was $345 million ($3.26 per capita), a 54% increase from 2010 (Edillo et al., 2015). 
When the same study estimates underreported DEN cases, healthcare costs equal the annual 
income of 242,000 Philippine people. The median cost of DENV-infected patient treatment 
throughout Pan America is $1,227/case (Shephard, 2011). Costs vary substantially between 
countries due to the value of the dollar and the variance of direct costs (Gonzalez, 2011), i.e. 
regional differences in medical costs. Proper health care facilities are not accessible to all DEN 
patients, hence underreporting occurs (Dick, 2012). Most DENV endemic countries have poor 
surveillance of DF/DHF/DSS. Research has shown that the impact of DF/DHF is on the same 
 
8 
 
order of magnitude as infectious diseases such as malaria, hepatitis, tuberculosis and bacterial 
meningitis (Meltzer et al., 1998). Over the past 30 years, DEN has become a major cause of 
morbidity and mortality in children throughout the tropics (Tolle, 2009). It has generated public 
attention and is feared by the general public, placing significant pressure on the health care 
system, especially during epidemics (WHO, 2005).  
One of the most important factors for prevention and control of DEN is surveillance 
(Ligon, 2004). An analysis of the costs associated with arboviral surveillance budget cuts in 
Australia shows that delaying control responses (e.g. application of pesticides, source reduction) 
causes an exponential increase in healthcare costs and number of human cases (Vazquez-
Prokopec et al., 2010). The use of proactive surveillance strategies (mosquito collection/testing 
along with human health records to determine risk assessment) for DEN outbreaks in Australia in 
2003 and 2009 attributed to less money spent on reacting to outbreaks ($115,000 and $1.1 
million spent on reacting, respectively) compared to a projected cost of $13 million and $382 
million if these strategies would have been delayed 4-6 weeks (Vazquez-Prokopec et al., 2010; 
Queensland Government, 2011). This shows that a proactive surveillance program may lessen 
the economic burden of disease outbreaks and prevent a significant number of human cases. 
The identification of high risk areas can assist vector control management by providing 
information of where funding and control measures would have the most impact (Hu, 2010). In 
most areas endemic for DEN, transmission of DENV varies seasonally and is highest during the 
rainy seasons (Wichmann and Jelinek, 2004). In third world countries, the close proximity and 
poor construction of houses and buildings, low access to health services and education and the 
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use of natural ventilation (i.e. no window screens) instead of air conditioning, facilitates the 
transmission of DENV (Gubler, 2002; Gonzalez, 2011). 
It is expensive to manage vectors of DENV. Ultra low volume (ULV) insecticide sprays 
have been used for years to control epidemics (Gratz, 1991). This is a very visible application; 
however, combined with the government stating that they have the epidemic under control, the 
public may feel a false sense of security, hence leading to reductions of personal vector control 
around their own homes (e.g. dumping water-holding containers) which may perpetuate the 
epidemic cycle (Gubler, 2002). Other measures can be taken to reduce the spread of DENV 
including the use of repellent, which should be applied to exposed skin or clothing and should 
contain DEET or picaridin (Pye, 2012). However, consumers should be aware that products with 
less than 10% active ingredient will likely only offer limited protection (one to two hours) and 
concentrations above 50% offer no added protection (National Travel Health Network and 
Centre [NaTHNaC], 2010). The larval stage of mosquito development is the primary target for 
mosquito control strategies including introduction of larval predators and larvicides and 
oviposition habitat elimination (removal of standing water) (Tolle, 2009). Window screens, air 
conditioning, mosquito coils and bed nets are advised (Wichmann and Jelinek, 2004; NaTHNaC, 
2010). While there is no vaccine (Whitehorn and Farrar, 2011; Meltzer and Schwartz, 2009), the 
best method of protection is prevention of mosquito bites with products like DEET as well as 
tipping over any water-holding containers (Mangold and Reynolds, 2013).  
Evolution of the Virus 
Dengue virus is a positive sense single stranded RNA virus (Holmes and Twiddy, 2002; 
Ross, 2010; Simmons, 2012). RNA viruses exhibit genetic variability due to high mutation rates 
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associated with RNA-dependent RNA polymerase (Drake and Holland, 1999). This high 
mutation rate increases virus biodiversity and potentially increases disease severity and 
difficulties with vaccine efficacy (Holmes and Burch, 2012). Unlike most other flaviviruses, 
DENV utilizes humans as a reservoir and amplification host. There are four genotypes of 
DENV-2 (the most virulent serotype) (Martina, Koraka and Osterhaus, 2009; Afreen et al., 
2014). The two most notable genotypes of DENV-2 are:  1) American; endemic in the Western 
Hemisphere and South Pacific islands for five decades (first isolated in Trinidad in 1953) (Dick, 
2012), and 2) Southeast Asian; first detected in the Americas (Cuba) in 1981. The Southeast 
Asian genotype has displaced the American genotype and is the more virulent form (Anderson, 
2006).  
Each DENV serotype is phylogenetically distinct (Kuno et al., 1998; Holmes and 
Twiddy, 2002). Phylogenies show the same branching order among the four DENV serotypes, 
with DENV-4 diverging first. The next serotype to evolve was DENV-2 followed by a split 
between DENV-1 and DENV-3 (Holmes and Twiddy, 2002). Serotypes may have originated 
independently due to geographic (allopatric) or ecologic partitioning in different primate 
populations (Holmes and Twiddy, 2002). Another hypothesis is that DENVs evolved together 
(sympatric), facilitating viral transmission through antibody-dependent enhancement (Ferguson, 
Anderson and Gupta, 1999; Tolle, 2009). 
Diagnosis of DEN is primarily carried out via Immunoglobulin M (IgM), an antibody 
produced by B cells (Whitehorn and Farrar, 2011). Nonstructural protein 1 (NS1) in DENV can 
be detected in the first few days of infection. Quantitative reverse transcription polymerase chain 
reaction (qRT-PCR) is a sensitive method for DENV detection, but is costly and required trained 
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personnel, hence, it is impractical for widespread use. A rapid sensitive test that detects NS1, the 
most common antibody [Immunoglobulin G (IgG)], and the largest antibody (IgM), allowing 
DENV identification throughout the intrinsic incubation period is needed (Whitehorn and Farrar, 
2011). Patients with DSS exhibit higher IgG compared to patients with DHF and DF (Khan et 
al., 2013). Khan et al. (2013) shows that most (72.7%) DSS patients required medical 
intervention compared to DHF (25.4%) and DF (6.1%) patients. Other diagnostic tests include 
DENV isolation in cell culture, but this is expensive, time consuming, and cannot differentiate 
between serotypes (Guzman and Kouri, 1996; Mangold and Reynolds, 2013).  
Dengue symptoms in vertebrate hosts 
There are a range of symptoms associated with DEN infection (Holmes and Twiddy, 
2002). The intrinsic incubation period (time between infection and symptoms) is three to seven 
days (Tavodova, 2012). Some patients are asymptomatic, while others experience flu-like 
symptoms (i.e. DF) (Simmons, 2012). Symptomatic patients may experience fever (>38.5⁰C), 
headache, vomiting, myalgia, irritability, lethargy, abdominal pain, joint pain, and/or macular 
rash (Reiter, 2010; CDC, 2012; Simmons, 2012; WHO, 2012). The duration of symptoms is 
three to seven days and most patients will recover (Yacoub and Wills, 2014). In some cases, 
infections can progress to DHF or DSS (Gubler, 2002; Simmons, 2012). Some patients 
experience increased vascular permeability (Tantawichien, 2012), hemoconcentration, 
hypoproteinemia, pleural effusions and ascites (Simmons, 2012; Yacoub and Wills, 2014). The 
symptoms of plasma leakage are hypotension, tachycardia, cold extremities and restlessness. 
Mortality of patients experiencing severe forms of DEN varies between 10 – 20% (Whitehorn 
and Farrar, 2011; Travodova, 2012). Globally, > 500,000 DEN-related cases/year require 
hospitalization (Holmes and Twiddy, 2002). If early treatment is received with aggressive fluid 
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replacement therapy, patient mortality is reduced to < 1% (Ligon, 2004; Whitehorn and Farrar, 
2011; Tavodova, 2012).  
In Asia, all four serotypes exist in sylvatic transmission with primates (Tavodova, 2012). 
Other mosquito species such as Aedes polynesiensis Marks, Aedes pseudoscutellaris Theobald, 
Aedes malayensis Colless, Aedes furcifer Edwards (Jupp and Kemp, 1993), Aedes taylori 
Edwards, Aedes luteocephalus Newstead and Aedes cooki Belkin can transmit DENV in the 
sylvatic cycle (Rosen et al., 1985). The majority of primates do not exhibit symptoms after 
infection with DENV (Tavodova, 2012; Vasilakis et al., 2012; Clark et al., 2013). Monkeys in 
the Macaca and Presbytis genera are most commonly infected with DENV in Asia (Homes and 
Twiddy, 2002). Laboratory studies performed with Rhesus macaque (Macaca spp.) monkeys 
(South, Central, and Southeast Asia) indicate positive tests for DENV in regional lymph nodes 
24 hours post infection (Rothman, 2013; Marchette et al., 2013). Studies performed with Macaca 
fascicularis Raffles monkeys (Southeast Asia) illustrates infection in sera by RT-PCR and virus 
isolation from all monkeys tested three days post infection (Bernardo et al., 2008). These species 
of Macaca did not exhibit symptoms of infection (Angsubhakorn et al., 1994; Bernardo et al., 
2008). 
Of the locally acquired human DEN cases in Florida in 2009, fever was reported by all 28 
patients; rash, myalgia, arthralgia, eye pain and headache were also commonly experienced 
(MMWR, 2010). Six Floridian patients had bleeding, including four patients with bloody urine, 
one with vaginal bleeding (menorrhagia), and one with nosebleeds (MMWR, 2010; 
Tantawichien, 2012). Menorrhagia is common (25%) among female adults with DF/DHF 
(Carles, Peiffer and Talarmin, 1999; Thaithumyanon et al., 1994; Tantawichien, 2012). Increased 
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liver enzymes have also been found during DEN infection (Kuo et al., 1992; Kalayanarooj et al., 
2007). Liver disease and encephalopathy are correlated in patients with DF/DHF, hence causing 
altered consciousness, seizures and coma due to encephalitis (Solomon et al., 2000). Autopsies 
show DENV replication can occur in bone marrow, midbrain, spleen, liver, kidney, and lymph 
nodes and the antigen can be found in the lymphoid cells of the spleen and thymus, necrotic liver 
tissue, thymus, lymph nodes, liver, spleen, lung and in skin cells (Perng, 2011). 
Epidemiologic studies have identified extremes in age (Hammond, 2005; Lee, 2006), 
high and low body mass index (Yacoub and Wills, 2014; Kalayanarooj, 2005), secondary 
infection (Guzman, et al. 2013), female sex, pregnancy (Machado, 2013), Caucasian race, AB 
blood type (Khan et al., 2013), virus strain, and genetic variants as risk factors for severe DEN 
and/or complications (Simmons, 2012). There is a significantly higher percentage of male 
patients during epidemics; however, females have also been associated with severe disease 
(Anders et al., 2011; Huy et al., 2013; Khan, 2013). In Asia, DF and DHF predominantly affect 
children (thought to be due to their developing immune systems and increased time spent 
outside), while in the Americas, all age groups are equally affected (Guzman, 2003; 
Tantawichien, 2012). Race plays a significant role in infection as DEN infections were found to 
be more prevalent in the Caucasian race when compared to African American and Asian (Bravo, 
Guzman and Kouri, 1987). Interestingly, DHF and DSS are more common in well-nourished 
children than in malnourished children, likely due to lower levels of the monocyte Tumor 
Necrosis Factor – Alpha (TNF-α) in malnourished children, causing a lesser immune response 
(Rothman, 2013). It has been hypothesized that malnutrition can suppress the cell-mediated 
immune responses found to be associated with severe DEN (Maron et al., 2010; Rothman, 2013; 
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Daniel et al., 2014). This is due to the need for a strong inflammatory response for severe forms 
of DHF and DSS (Halstead, Chow and Marchette, 1973; Lei et al., 2001; Maron et al., 2010). 
Despite the known symptoms, the majority of DEN infections are asymptomatic, making 
it difficult to diagnose or determine the extent to which it affects public health because they are 
diagnosed as non-differential fevers of unknown etiology, masking the prevalence of DEN 
(MMWR, 2010). Most imported DEN cases are never reported due to the association with flu-
like illness (Gubler, 1998). This makes it virtually impossible for mosquito control programs to 
be effective, because information on infection rates is essential to take actions such as targeted 
mosquito control (MMWR, 2010). The ability to diagnose DEN in the early stages, combined 
with the ability to predict the patients who are more at risk for developing severe disease would 
significantly aid clinical management of DEN (Whitehorn and Farrar, 2011). If regions are 
unable to manage the disease, there is an increase in mortality due to overloading of clinics and 
hospitals, overworked medical staff, and sub-standard care for patients with severe DEN 
(Gubler, 2002; Tolle, 2009).  
Mosquitoes 
 Mosquitoes are responsible for more human suffering worldwide than any other organism 
(AMCA, 2011). There are 3,500 mosquito species found throughout the world (Tolle, 2009). The 
two main DENV vectors are Ae. aegypti and Ae. albopictus. Aedes aegypti was not originally a 
domestic mosquito, but adapted to peridomestic settings in Africa (Weaver, 2010) and is now 
commonly found in urban areas in tropical climates (Maciel-de-Freitas et al., 2013). Aedes 
aegypti was likely transported into the Americas via ships (Gubler, 2002; Weaver, 2010). Female 
Ae. aegypti use artificial water-holding containers (e.g. buckets, bird baths, water storage barrels, 
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tires) as oviposition sites (Vezzani and Carbajo, 2008; Holmes and Twiddy, 2002; Ligon, 2004) 
and preferentially feed on human blood (anthropophilic) as a protein source for egg development 
and energy (Briegel, 1985; Harrington, Edman and Scott, 2001; Tolle, 2009; Weaver, 2010). 
Larval development time depends on environmental conditions including nutrients, day length, 
and temperature, i.e. most larvae develop into adults in approximately one week (Tolle, 2009). In 
temperate zones, larvae may overwinter (White, Cook and Zumla, 2004). Aedes albopictus is a 
day biting species that was originally a forest species found in Asia, which began a geographic 
expansion in the 1980s and is still expanding today (Lambrechts, 2010). Aedes albopictus was 
introduced into Texas in 1985 in a shipment of tires from Asia (Hawley et al., 1987; Gubler, 
1998; Benedict et al., 2007) and introduced into California in 2001 in a shipment of “Lucky 
Bamboo” imported from China (Kuno, 2012). This species can survive in both temperate and 
tropical regions (Rezza, 2012). Aedes albopictus blood feeds on humans and domestic animals 
and oviposits in both natural and artificial containers that hold water (Lambrechts, 2010). Natural 
containers include bromeliads, tree-holes, and bamboo stumps (Marques, Santos and Forattini, 
2001). Temperatures above 32.2°C reduce longevity of Ae. albopictus, while temperatures 
15.5°C-22.2°C increase lifespan (Kuno, 2012). Aedes albopictus eggs can diapause, allowing the 
species to survive/overwinter during cold temperatures in which adult mosquitoes could not 
survive (Pumpuni, Knepler and Craig, 1992; Hanson and Craig, 1995; Brady et al., 2013). Aedes 
aegypti eggs cannot survive such extreme temperatures (Fischer et al., 2011). The eggs of both 
potential vectors are desiccation-resistant and can remain viable for over a year out of water (Liu 
et al., 2011; Rezza, 2012). 
Even though Ae. albopictus can survive in both rural and urban areas, Ae. aegypti is 
considered a better vector of DENV (Lambrechts, 2010; Rezza, 2012). Some explanations of this 
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include:  1) Ae. aegypti is adapted to urban environments while Ae. albopictus prefers suburban 
or rural settings due to increased vegetation density (Lambrechts, 2010), 2) Ae. aegypti prefers to 
bite humans over other hosts (Scott et al., 1993; Harrington, Edman and Scott, 2001; Ponlawat 
and Harrington, 2005; Lambrechts, 2010) and is a competent vector of DENV, yellow fever 
virus, chikungunya virus, Zika virus and West Nile virus (WNV) while Ae. albopictus is an 
opportunistic feeder and has been shown to vector > 22 pathogens (Tiawsirisup, 2003; Gratz, 
2004; Vega-Rua et al., 2013), 3) Ae. aegypti stops feeding at the slightest movement and will 
either return to the same or a different host to continue feeding (Gubler, 1998; MMWR, 2010) 
and will feed exclusively on humans if given the opportunity (Ponlawat and Harrington, 2005). 
Aedes aegypti may feed on multiple human hosts during a single gonotrophic cycle, hence 
increasing its probability of becoming infected and transmitting a pathogen to another host 
(Weaver, 2010; Rezza, 2012). It is common to find members of the same household infected 
with DF within a 36 hour period, possibly infected by the same mosquito (Gubler, 1998; 
Mangold and Reynolds, 2013).  
Dengue virus can invade the mosquito’s brain tissues, which can modify mosquito 
metabolism and physiology, hence changing life-history traits involved in vector competence 
(Putnam and Scott, 1995; Maciel-de-Freitas et al., 2013). Dengue virus-infected Aedes aegypti 
feed on multiple hosts more frequently compared to uninfected mosquitoes due to virus-induced 
increase (up to 50%) in locomotor activity (Lima-Camara et al., 2011). This may increase bite 
rate and potentially increases the chance of mosquitoes infecting naïve hosts (Lima-Camara et 
al., 2011). The lifespan of Ae. aegypti is ca. 40 days (MMWR, 2010), depending on a variety of 
biological and environmental factors. Increased larval development time and mortality in Ae. 
aegypti are associated with low temperatures, resulting in decreased transmission (Alto and 
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Bettinardi, 2013). The same study showed that, if temperatures are lower than 16˚C, larval 
development is slowed, adult mosquitoes stop feeding, and DENV cannot replicate inside the 
vector, hence decreasing vector population growth and subsequent transmission.  
Higher temperatures shorten the extrinsic incubation period of DENV, increase the 
development rate of immature mosquitoes, and increase blood feeding rate (Johansson, 2008), 
hence increasing the likelihood of DENV transmission. Johansson (2008), conducted a 20 year 
analysis to determine the association between temperature and precipitation with DF in 77 
municipalities of Puerto Rico. Monthly variation in temperature was positively associated with 
DF in most municipalities (Johansson, 2008). However, in areas where temperature and 
precipitation were already high (30°C and 1,800 mm/month, respectively), increases in 
environmental variables did not affect the number of DF cases reported (Johansson, 2008).   
Dengue in Pan America and the United States 
During the 19th century, DEN outbreaks were frequent throughout port cities in the 
Caribbean, South, Central and North America due to commercial activities (Guzman and Kouri, 
2003; Halstead, 2006; Dick et al., 2012). A DEN outbreak in Galveston, Texas in 1918 was 
followed by another outbreak in 1922 with an estimated 30,000 cases (Rice, 1923). Following 
the route of the South Pacific Railroad, this DEN outbreak expanded throughout Texas, 
Louisiana, Florida, and Georgia (Dick et al., 2012). An extended epidemic affecting ca. 10% of 
the population in Florida started in Miami in 1934 and then spread to the rest of Florida and 
southern Georgia (Griffitts, 1935; Mac Donell, 1935). Between 1941 and 1946, DEN continued 
to spread throughout the region with multiple outbreaks in Texas (Dick et al., 2012). During 
1946-1979, there were no cases of locally acquired DEN in the continental US (MMWR, 2010). 
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The first case in Texas since 1946 was in 1980 with 14 more cases in Texas in 1986 (Rigau-
Perez, Gubler and Vorndam, 1994). From 1980-1992, no further locally acquired cases were 
reported in the US. On September 1, 2009 a New York state resident whose only recent travel 
was to Key West, Florida became the first confirmed case of locally acquired DF in the US 
(MMWR, 2010) since 1986. During the next two weeks, two residents of Key West who had no 
record of recent travel were confirmed to have DEN. After this, 24 more human cases in local 
residents were confirmed in Key West (MMWR, 2010). In Florida, there is potential for DENV 
transmission due to international travelers and visitors to the region, a largely non-immune 
population, and the invasiveness of both Ae. aegypti and Ae. albopictus. From 2001 to 2002, 122 
patients in the US tested positive for DENV antibodies. Some of the patients were from Hawaii 
and were the first cases in Hawaii since WWII (Effler et al.,2005; Halstead, 2007).  
One of the most important factors in the increasing incidence of DEN is the lack of 
effective mosquito control (Gubler, 2002; Tolle, 2009; Edillo et al., 2015). Another factor is 
demographic changes (e.g. high population growth rate and increased urbanization) (Gubler, 
1998; Tantawichien, 2012), resulting in poor housing, inadequate water supply/sanitation, 
thereby increasing oviposition sites due to domestic water-holding containers (Brightmer, 1998; 
Gubler, 2002; Ligon, 2004; Edillo et al., 2015). Increases in air travel allow DENV (and 
potentially, its vectors) to spread globally (Gubler and Trent, 1994; Gubler, 1998; Tantawichien, 
2012). During the 1980s there was a reduction in public expenditures for mosquito control, 
thereby causing emergency responses to outbreaks instead of surveillance-based targeted control 
(Brightmer, 1998). The importance of mosquito control programs (MCPs) are often 
underestimated because of their inability to create revenue, hence, are often subject to funding 
cuts (Herring, 2010; Harris et al., 2014; del Rosario et al., 2014). With the emergence and swift 
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spread of WNV in the US in 1999 resulting in a substantial supplement of government funding, 
several MCPs were created to combat WNV (Herring, 2010; Vasquez-Prokopec, 2010; Harris et 
al., 2014). However, WNV has become less of a concern to the public in recent years and MCPs 
budgets have declined (del Rosario et al., 2014). Mosquito control budget reductions continue 
today, increasing both the cost of control (e.g. reaction to epidemics) and the number of human 
cases of vector-borne disease (Herring, 2010; Vazquez-Prokopec et al., 2010). The detection of 
and response to vector-borne diseases can be severely impaired without a strong surveillance 
system for human/veterinary cases and potential vectors (Franco et al., 2010; Vasquez-Prokopec 
et al., 2010). Without CDC funds for vector control and testing, the testing of potential vectors 
would be halted, causing detection of transmission and new viral introductions into the US to be 
significantly delayed. This would turn a potentially proactive system into a reactive system, 
which is currently what the US utilizes (Couzin-Frankel, 2010; Vasquez-Prokopec et al., 2010). 
In many countries in Pan America, the lack of water treatment services results in 
improper water storage and lack of trash collection, causes accumulation of waste receptacles 
holding rainwater and supports larval development (Whitehorn and Farrar, 2011; Tavodova, 
2012). This contributes to urban Ae. aegypti infestations (Weaver, 2010; Medeiros, 2011; 
Simmons, 2012). Global warming also may facilitate DENV transmission due to the geographic 
expansion of the vectors (Gratz, 199; Weaver, 2010). A rise of 2°C would increase the risk of 
DENV transmission in South America by five times and new transmission areas would be 
expected in the southern part of the South American continent (Githeko et al., 2000; Vezzani and 
Carbajo, 2001). 
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In 2003, the Integrated Management Strategy for Dengue Prevention and Control (IMS-
Dengue) was approved by the Pan-American Health Organization. This six component model 
includes 1) entomology, 2) epidemiology, 3) environment, 4) healthcare, 5) laboratory, and 6) 
social communication (Dick, 2012). This strategy utilizes individual modification techniques to 
decrease risk factors for DENV transmission. The entomology portion establishes a system of 
entomologic surveillance by applying the Integrated Vector Management approach which 
focuses on education, environment, public works and the academic sector (Guzman, 2010; 
Ligon, 2004). Epidemiologic surveillance ensures that public health policies have an 
interdisciplinary, intersectional and multisectorial focus (Guzman, 2010). Health care ensures 
that proper training has been administered to health workers to identify treatment and disease 
properly and inform the community of the warning signs. Pre-travel advice and post-travel 
follow-up of patients who have traveled to endemic areas is necessary so the patient can have a 
comprehensive understanding of dengue (Pye, 2012). The laboratory sector ensures that a 
laboratory is available for the surveillance system which includes an integrated network of 
available laboratories to call upon if help is needed or an intervention needs to be designed 
(Guzman, 2010). Finally, social communication strengthens the effectiveness and sustainability 
of national strategies through community participation.  
Dengue and Travel   
Dengue is the most diagnosed arboviral illness in travelers (Cleton, 2012). Three to eight 
percent of travelers with febrile disease are DENV-positive via serology (Cleton, 2012; Mangold 
and Reynolds, 2013). The majority of DF cases in the US are in US residents returning from 
vacation in Central and South America (Mangold and Reynolds, 2013). Dengue is 
underdiagnosed, hence the infection risk could be significantly higher than currently reported 
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(Cleton, 2012). In a serological survey done in the US between 1986 and 1992, 40% of positive 
tests came from patients who had travelled to Latin America or the Caribbean (Rigau-Perez, 
Gubler and Vorndam, 1994). In 2010, 162,058,000 visitors entered the US (WTO, 2012). Brazil 
is endemic with all four serotypes of DENV and had 5,161,000 visitors in 2010 (WTO, 2012). 
As travel continues to increase, so does the risk of being bitten by a mosquito infected with 
DENV (Gubler, 1998; WTO, 2007; Dick, 2012). In 1994, ca. 40 million people left the US by air 
and 50% travelled to tropical countries where DENV is endemic (Gubler, 1998). Many people 
become infected while traveling but do not exhibit symptoms until after they return home 
(Gubler, 1998). The constant movement of humans infected with DENV causes repeated 
introductions of new serotypes into different geographic regions (Rigau-Perez, 1994). By 
tracking travel to and from DENV-endemic countries, risk assessments may be improved. 
Vector Competence for DENV 
Mosquitoes acquire pathogens via blood meal (Beerntsen, 2000). Vector competence is 
the intrinsic permissiveness of a vector to infection, replication and transmission of a virus 
(Bennett, 2002; Guo, 2013). Estimates of a vector’s capacity to transmit pathogens consider 
cellular, behavioral, environmental, and biochemical factors that influence the association 
between the vector, the pathogen, and the vertebrate host to which the pathogen is transmitted 
(Beerntsen, 2000). Vector competence is associated with a number of barriers to infection, i.e. 
midgut infection and escape, salivary gland infection and escape. In vectors that have a midgut 
infection barrier, the virus cannot infect and/or replicate in midgut cells (Salazar et al., 2007). 
The cause of this may be a lack of cell surface receptors for the virus or the midgut cells may not 
be permissive for infection with the virus (Bennet, 2002). Vectors with a midgut escape barrier 
may allow the virus to enter and replicate in the midgut, even to high concentrations, but the 
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virus will not be able to escape midgut tissues. Aedes aegypti populations exhibit considerable 
genetic variation causing a wide range of vector competence, which may explain, in part, the 
large variance in the epidemiology of DENV (Bennet, 2002). Pathogens and microbes inhabit the 
same environment prior to infection (e.g. mosquito midgut) and infection is decreased in vectors 
harboring some species of bacteria (Ramirez, 2012). Bacteria can deter DENV replication by 
boosting the mosquito’s immunity (Ramirez, 2012), whereas fewer bacteria in the midgut 
decrease barriers to DENV replication (Ramirez, 2012). Midgut bacteria can also increase vector 
competence for DENV in Ae. aegypti (Mourya et al., 2002). Viruses may also change the midgut 
bacteria composition in Ae. albopictus (Zouache et al., 2012). For example, under the condition 
of the study performed by Zouache et al (2012), infection with chikungunya virus promotes 
growth of Protobacteria and decreases the presence of Alphaprotobacteria (Zouache et al., 
2012). The geographic expansion of mosquitoes may be related, in part, to the symbiotic 
relationship between vectors and microorganisms such as bacteria (Zouache, 2012). There are 
multiple viral replication sites in the mosquito including the midgut, malpighian tubules, thoracic 
musculature, and salivary glands (Beerntsen, 2000). Mosquito genetics can play a role in the 
success of pathogen replication (Beerntsen, 2000). However, the genetic makeup of a virus or 
parasite can also impact whether the virus can replicate in the mosquito (Beerntsen, 2000). 
Therefore, pathogen-vector interactions are a complicated system and determine whether 
replication and transmission occur (Beerntsen, 2000). The midgut is a hostile environment for 
pathogens due to differences in pH, temperature, and blood digestion enzymes (Champagne, 
2005). For most pathogens, replicating in and exiting the midgut quickly increases pathogen 
survival rate (Beerntsen, 2000). Mosquitoes have immune systems and, despite their best efforts, 
many pathogens are able to develop and replicate within them (Beerntsen, 2000). 
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Anderson and Rico-Hesse (2006) determined that mosquitoes fed simultaneously on both 
the American and Southeast Asian DENV-2 genotypes were more likely to become infected with 
the Southeast Asian (21% of mosquitoes) compared to American (3% of mosquitoes) genotype 
(Anderson and Rico-Hess, 2006). In the same study, McAllen (Texas) Ae. aegypti females were 
reared at 28˚C with 75% humidity and a 14:10 light/dark cycle and fed defibrinated rabbit blood 
containing either the Southeast Asian or American strain of DENV-2 virus at 2.5 x 108 genome 
equivalents/mL. After feeding, mosquitoes were kept at 30˚C for up to 14 days (Anderson and 
Rico-Hess, 2006). In the same study, by day four post infection, 80% of midguts were positive 
with Southeast Asian genotype compared to 45% infected with the American genotype. The 
same occurred with the salivary glands where at day seven, 50% of the mosquitoes fed the 
Southeast Asian strain were virus-positive, while it took until day 14 post-infection for the 
American strain to reach 50% infection of mosquitoes. It was determined that the Southeast 
Asian strain replicated to a higher level than did the American strain (Anderson and Rico-Hess, 
2006). 
The biological makeup of ingested blood may influence vector competence (Beernsten, 
2000). Vectors have evolved mechanisms that improve blood uptake from the host and the 
vertebrate hosts have developed mechanisms to prevent blood loss (Beerntsen, 2000). 
Antihemostatic mechanisms exhibited by Ae. albopictus and Ae. aegypti are found in the saliva 
(Beerntsen, 2000). Components in mosquito saliva are vasodilators, anticoagulants and platelet 
aggregation inhibitors (Champagne, 2005). Mosquitoes have Adenosine Tri-Phosphate and 
Adenosine Di-Phosphate (ATP/ADP) diphospholhydrolase. The enzyme works by depleting the 
ADP and ATP from the bite site so that platelets cannot block the wound and repair cannot take 
place (Champagne, 2005). The next enzyme is an anticoagulant such as prolixin-S which 
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facilitates blood flow to the mosquito (Beerntsen, 2000; Champagne, 2005). The ingested blood 
may display different viscosities due to coagulation in the midgut and this can inhibit ingested 
pathogens from migrating into and out of the midgut (Beerntsen, 2000). The viscosity of the 
ingested blood can influence the prevalence and intensity of infection depending on the duration 
of virions in the midgut (Beerntsen, 2000).  
Dengue Vaccines 
In order to create a vaccine that will be viable and safe for humans, a life-long tetravalent 
immunity against all four serotypes of DENV will be needed (Weaver, 2010; Whitehorn and 
Farrar, 2011). Due to antibodies produced after vaccination, infection with any DENV strain 
could result in unfavorable outcomes because of activity of non-protective, cross reacting 
enhanced antibodies (Perng, 2011). An ideal DEN vaccine should have a rapid immunization 
regime that can fit in with the already established vaccine programs and be administered in one 
or two doses. It must also be easy to store and transport, affordable, genetically stable, provide 
long-lasting immunity and should not contribute to immunopathogenesis through vaccine-
induced enhancement (Webster, Farrar and Rowland-Jones, 2009). Live attenuated vaccines are 
at a relatively advanced stage of clinical development (Sabchareon et al., 2002; Durbin, 2011) 
though the ability to develop a tetravalent live attenuated vaccine against all four DENV 
serotypes has been difficult. Phase III trials (based on the yellow fever 17D virus) of a live 
attenuated tetravalent chimeric vaccine produced by Sanofi Pasteur are ongoing (Durbin, 2011). 
However, the current ideal vaccine model requires three doses given over a 12 month period in 
order to fully induce the neutralizing antibodies to all four serotypes (Durbin, 2011). DNA 
vaccines could be another option in the future, which induce humoral and cellular immune 
responses much like those of live attenuated virus, but do not cause the same safety issues of the 
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live virus vaccines (Durbin, 2011). In Durbin’s (2011) study, only partial protection was 
observed against DENV-1 while no protection against DENV-2 was observed. There are also 
recombinant adenovirus vectored DEN vaccines in development that can be administered on a 
smaller dosing schedule and can induce more potent immune responses than DNA vaccines 
(Durbin, 2011). Although control for DEN by widespread vaccination has been a priority for the 
WHO for three decades, a licensed vaccine is still not available (Brandt, 1990; Webster et al., 
2009).
 
 
Chapter 3 - Dengue in Pan America 2001-2012:  Trends in Cases Imported into the United 
States 
*Note: This chapter is formatted as a complete manuscript and will be submitted to a peer-
reviewed journal in the future. Hence, there may be some repetition in Chapter 2 (Literature 
Review) and the Introduction for Chapter 3. 
Abstract 
 Risk assessments showing the impact of travel on the importation of dengue virus 
(DENV) are essential to understand the role of human travel in the spread of this mosquito-borne 
pathogen for which humans are the primary reservoir. Consequently, we calculated the exposure 
risk of United States (US) citizens traveling into Pan American countries where dengue (DEN) 
fever is endemic. The number of DEN cases in 51 Pan American countries was compared to the 
population of the same countries from 2001-2012 as a measure of exposure risk. Travel statistics 
(i.e. US travelers visiting the 51 Pan American countries) were analyzed and categorized by 
geographical region (i.e. North America, Central America, Andean, Southern Cone, Hispanic 
Caribbean and English, French and Dutch Caribbean). Travel patterns for US citizens were 
compared with subsequent DEN infections for each region visited. We show that US travelers 
visiting the Dominican Republic exhibited the highest number of imported DEN infections for 
the period of study. The Pan American country with the most DEN cases in its residents was 
Brazil (> 1 million reported cases in 2010). The numbers of DEN cases in Pan America 
continues to rise as does international travel and the geographic range of potential DENV 
vectors. Hence, in order for DENV risk assessments to improve, we must analyze possible routes 
of entry for this pathogen. There is also an increased risk of introducing new DENV serotypes 
into naïve human populations. Regions where all four DENV serotypes are prevalent are at the 
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highest risk for DHF and DSS. Underreporting and misdiagnosis remains an issue for calculating 
DENV transmission risk and this is discussed.  
Introduction 
Dengue fever (DF) is the most diagnosed traveler-related illness with 390-400 million 
cases/year worldwide (Bhatt, 2013; Cross, 2013; Yacoub and Wills, 2014) and an incidence rate 
of ca. 2.5-5% of the > 2 billion people at risk (Suaya, Shepard and Beatty, 2006) (Figure 1). 
Only an estimated 3-8% of symptomatic travelers are positive for DENV via serological tests 
(Cleton, 2012). Infection with one DENV serotype may cause a range of symptoms (e.g. 
asymptomatic, flu-like). However, a simultaneous and/or sequential infection with different 
serotypes increases the risk of serious illnesses such as dengue hemorrhagic fever (DHF) and 
dengue shock syndrome (DSS), which could lead to death (Durbin, 2011). Often, patients are 
unaware of initial infection and experience severe symptoms when superinfection with another 
serotype occurs (Durbin, 2011). An understanding of human travel patterns between DEN-
endemic countries and the US will improve risk assessments and identify potential routes of 
entry for DENV. The geographic ranges of the four DENV serotypes are expected to expand 
with international travel as humans are the primary reservoirs (Gubler, 2012). This increases the 
likelihood of multi-serotype epidemics that could impact public health. Risk assessments 
showing the impact of travel on importation of DENV are essential to understand the role of 
human travel in pathogen spread.  
Pan America can be categorized into four regions, i.e. North America, Central America, 
South America, and Caribbean. Most DEN cases among US citizens occur as a result of endemic 
transmission in Puerto Rico, a US territory (CDC, 2013). In 2010, 162,058,000 visitors entered 
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the US (WTO, 2011). Of those, 1,197,866 were Brazilian (OTTI, 2010). Dengue is endemic in 
Brazil where all four serotypes of DENV circulate (PAHO, 2009). Travelers returning to the US 
from Brazil accounted for 70% of DEN cases between 1998 and 2008 (Mangold and Reynolds, 
2013, San Martin et al., 2010). 
Globally, > 2 billion people/year are at risk for DEN infection and > 21,000 DEN-related 
deaths/year occur, yet the range of expected symptoms makes it difficult for medical diagnoses 
without a serological test (Simmons, 2012). Studies have identified young age, high body mass 
index, female sex, virus serotypes, and virus genotype as risk factors for severe DEN (Simmons, 
2012). Patients recovering from DHF may experience symptoms such as fatigue for up to six 
months (Simmons, 2012). These increased risks are important due to the economic burden of lost 
work time and associated medical costs (MMRW, 2010; Rothman, 2013, Gubler 1998). A study 
of 2012 healthcare costs in the Philippines reported $345 million ($3.26 per capita) spent in 
direct medical costs for DEN patients (Edillo et al. 2015). In Pan America, DEN cost ca. $2.1 
billion/year in medical costs (Shepard, 2011). In the US, each person hospitalized from DEN 
pays ca. $17,803 and less severe cases cost ca. $1,610 (Shephard, 2011). The median cost of 
treatment throughout Pan America is $1,227 USD (Shephard, 2011). Costs vary substantially 
between countries due to the value of the dollar and the variance of direct cost, i.e. difference in 
costs between hospitals (Gonzalez, 2011). Proper health care facilities are not accessible to all 
DEN patients, hence underreporting occurs (Dick, 2012) 
Dengue emerged in Africa between the 15th and 19th centuries during slave trades 
(Weaver, 2010). Dengue virus was first isolated in 1943 and serological tests were subsequently 
made available (Dick, 2012). Currently, DEN cases are diagnosed based on symptoms rather 
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than serological tests that are used simply to confirm infection for research (Dick, 2012). Before 
1970, DEN had only been detected in nine countries; however, by 1996, 102 countries had 
experienced epidemics (Dorji, 2009). In 1962, a comprehensive mosquito control effort was 
developed and implemented by the Brazilian government, Pan American Health Organization 
(PAHO) and the Rockefeller Foundation (Dick, 2012). Although this effort attempted to 
eradicate the primary DENV vector, Aedes aegypti L., re-infestation occurred when plans 
deteriorated due to the loss of political interest (Dick, 2012, Mangold and Reynolds, 2013).  
Insufficient community participation and a lack of support from the health sector added to the 
deterioration of the eradication program (Dick, 2012). By 1980, DEN outbreaks increased 
globally and, in 1981, Cuba experienced an outbreak with 344,203 cases, including > 10,000 
DHF cases and > 150 deaths (Dick, 2012). From 2000-2012, all four DENV serotypes were 
found in Pan America, causing the highest number of cases to date (Dick, 2012). 
Aedes aegypti and Ae. albopictus Skuse are the two primary vectors of DENV and are 
distributed through Pan America (Simmons, 2012). Aedes albopictus, a day-biting species 
originally found in Asia, began geographic expansion in the 1980s and is still expanding today 
(Lambrechts, 2010). This mosquito species was introduced into the US in 1985 from Asia in a 
shipment of tires (Hawley et al., 1987; Gubler, 1998; Benedict et al., 2007) and is anthropophilic 
(Higa, 2011). Aedes aegypti takes multiple blood meals, hence, this species may infect multiple 
humans during a single gonotrophic cycle (Weaver, 2010). This mosquito species will stop blood 
feeding when disturbed and either return to the same host or a different host to complete a blood 
meal (MMWR, 2010; Gubler, 1998). While both species oviposit in artificial containers with 
standing water, Ae. albopictus often oviposits in natural containers (Lambrechts, 2010). Aedes 
aegypti is considered a better DENV vector because of its adaptation to urban environments in 
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tropical cities in close proximity to humans. Aedes albopictus is better adapted to suburban and 
rural settings with vegetated areas facilitating its preferred larval development and resting sites 
(Lambrechts, 2010). Warm temperatures in many Pan American countries shorten the extrinsic 
incubation period of DENV and increase the development rate of the vector. These factors 
increase the likelihood of a vector successfully transmitting a virus (Johannson, 2008). Rapid 
expansion of international and domestic human travel, urban sprawl, and insufficient vector 
control may facilitate the geographic expansion of DENV (Dick, 2012). 
Some of the most visited countries in the world are in Pan America (CTS, 2011). Here, 
we conduct a risk assessment for 2001-2012 based on:  1) visitors from 51 Pan American 
countries traveling to the US, and 2) the total number of residents and DEN cases in 51 Pan 
American countries. We expect this analysis to facilitate models interested in assessing risk of 
traveler-imported infections and the risk of importing DENV into the US. 
Materials and Methods 
Travel statistics for 51 Pan American countries were tabulated from the Compendium of 
Tourism Statistics and the Office of Travel and Tourism Industries between 2001-2012 (Table 1) 
(OTTI, 2013). Countries were categorized by geographical region (i.e. North America; Central 
America; South America and Caribbean) (US Census Bureau, 2013). Populations of these 51 
countries were tabulated (Table 2) (US Census Bureau 2013). Numbers of clinical DEN cases 
were identified and counted from the Pan American Health Organization (PAHO, 2013) and the 
Centers for Disease Control and Prevention (Jennifer Lehman [CDC], personal communication). 
Numbers of DEN cases were compared to annual travel statistics and populations for each 
region. Regions with the most visitors to the US were ranked and analyses were conducted for 18 
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countries whose residents visited the US most frequently. The incidence rate was determined 
(the number of DEN cases in the country/the population of the country). Next, the infection rate 
was calculated (the number of DEN cases reported for each country was divided by its respective 
population and multiplied by 100,000). To determine the number of infected people potentially 
traveling to the US, we multiplied the infection rate by the number of individuals traveling to the 
US from these 18 countries for each year between 2001-2012. To determine the risk of traveling 
to an endemic country and becoming infected, the number of US citizens traveling to each region 
was multiplied by the infection rate for that region. This method was repeated for each 
consecutive year studied. The CDC provided information on DEN cases imported into the US by 
US citizen travelers from 2003-2011 (Jennifer Lehman, personal communication). The numbers 
of DEN cases from each of the 18 Pan American countries was divided by the total number of 
cases for each year to determine the visited country where the highest rate of infections occurred 
in US travelers. 
Maps were created using Environmental Systems Research Institute (ESRI) ArcMap 10.1 
(Redlands, California) and 18 Pan American countries were selected as map layers. Infection 
rates (PAHO, 2001-2012) calculated were input into attribute tables for specific countries. 
Graduated colors were used to display the numbers of DEN infections/100,000 people for each 
country. Maps were created for years 2004, 2008 and 2012 because available data was more 
complete starting in 2004 for the countries relevant to our study.  
Results 
We generally observed yearly increases in international travel to the US from all regions 
of Pan America from 2001-2012 (Figure 2). For the time period studied, most Pan American 
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DEN cases occurred in Brazil (South American Region) in 2010 (> 1 million reported cases) 
(Table 1). For US citizens, the highest number of imported DEN cases was observed in 
continental US travelers visiting the Dominican Republic, closely followed by Puerto Rico 
(Caribbean Region) (Jennifer Lehman, CDC, personal communication). Table 1 shows that 
reported clinical cases of DEN have increased where surveillance systems have become a 
priority, such as Brazil (mandatory reporting started in 2007). Until 2009, DEN was not a 
nationally reportable disease in many Pan American countries, including the US; hence, cases 
prior to 2009 may be underreported. Some countries only report serologically positive cases, 
hence, physician-diagnosed cases (relying solely on symptoms) may be underreported (PAHO, 
2010). The South American Region has the highest number of DEN cases over the 12 years 
studied (Figure 3). Infection rates in all regions have increased since 2001 with the worst 
epidemics occurring in 2010 (Figure 4). Of the 18 countries studied, Brazil (3rd highest number 
of travelers to US) had the highest number of DEN cases. The DEN infection rate was highest in 
the South American region (341 cases/100,000 people in 2010), primarily attributed to Brazil. 
The Caribbean and South American regions both experienced DEN epidemics in 2010 while 
Central America had an epidemic in 2009 (Figure 3). However, there is a large population 
difference between the South American Region and other regions such as the Caribbean and 
Figure 4 accounts for these differences, i.e. regional infection rate with the population taken into 
account (incidence rate). While South America still has the highest infection rate, including the 
population in the equation demonstrates the severity of DEN in the Caribbean. 
We determined the potential number of infected travelers entering the US for each year 
studied (Figure 5). In 2010, Brazil documented four DENV serotypes and experienced the largest 
DEN outbreak in Pan America during the period of study (2001-2012). Mexico had the highest 
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number of potentially infected travelers visiting the US, i.e. highest in 2009 with > 29,000 
potentially infected travelers (Figure 6). Figures 7-9 show DEN incidence (serologically positive 
cases/100,000 people) in 2004, 2008 and 2012, respectively. In 2004, several countries had 
incomplete data available, due, in part, to underreporting. Countries with higher infection rates 
have at least three DENV serotypes circulating (e.g. Brazil, Venezuela, and Mexico) and its 
residents travel to the US most frequently. Table 2 shows that the number of DENV serotypes in 
most countries increased between 2004 and 2012. 
Discussion 
 Countries endemic for DEN pose a higher risk for travelers and thus create a higher risk 
for spread of DENV back to the home country. As travel and geographic range of potential 
DENV vectors continue to increase, incidence of DEN will likely increase (Gubler, 1998). There 
is also an increased risk of introducing new DENV serotypes into naïve populations. Highly 
traveled regions where all four DENV serotypes are prevalent (e.g. South America) pose the 
greatest risk. While underreporting and misdiagnosis remain an issue for calculating DENV 
transmission risk, we observed increases in case frequency. Because DEN is not nationally 
reportable in many countries, it is often underreported. Many patients infected with one serotype 
of DENV are asymptomatic or experience flu-like symptoms and do not seek medical treatment 
(Gubler, 2004). Others cannot afford to go to the doctor or do not have easy access for treatment 
and, therefore, go unreported (Gubler, 1998). There is a lack of uniform application of the case 
definition of DEN and some countries have instituted their own case definitions (Deen, et al., 
2006). In addition, complicated reporting systems and/or lengthy reporting requirements may 
reduce motivation of health-care workers to submit positive test results (Suaya et al., 2006). 
Underreporting impacts public health because it is an enormous barrier to obtaining an accurate 
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risk assessment. In Belo Horizonte, Brazil, the level of reporting of hospitalized DEN patients 
was ca. 63% between 1997 and 2002 (Duarte and Franca, 2006). Tests for virus by cell culture or 
nucleic acid detection (PCR) require sophisticated laboratories (Pediatric Dengue Vaccine 
Initiative [PDVI], 2006) and there is limited accuracy in rapid tests (Suaya et al., 2006). As a 
result, the mobilization of resources from the local, national and international communities for 
the elimination of the vector and better infection care (Suaya et al., 2006) needs improvement.  
Aedes albopictus and Ae. aegypti are both found in the US, hence traveler-imported cases 
are a concern for some regions since local mosquito populations may become involved in 
subsequent transmission. Florida had 125 locally transmitted cases from 2009-2014, while 
Hawaii (4 cases in 2011), Texas (24 cases from 2013) and New York (1 case in 2013) also 
experienced locally transmitted cases (MMWR, 2009, 2010; USGS, 2014). There were 177 
human DEN cases from 22 different states reported to CDC Arbonet in 2009, 642 cases from 39 
states in 2010, 245 cases from 32 states in 2011, 544 cases from 34 states in 2012, 772 cases 
from 41 states in 2013, and 357 cases from 37 different states in 2014 (Jennifer Lehman, 
personal communication; USGS, 2014).  
 There is currently no DEN vaccine (Meltzer and Schwartz, 2009) and there is great 
concern for people who have already been infected with one or more serotypes and how they 
would react to the vaccine (Messer et al., 2014). As more serotypes become endemic in more 
countries, the risk for becoming infected and the potential for DHF increases. With > 43 million 
travellers entering the US by air from Pan American countries, the risk for travel related DEN 
exists. Continued surveillance and risk assessment is needed to prevent further DEN expansion 
and reduce the risk of importation.
 
 
Chapter 4 - Effects of Blood Meal Source on Aedes albopictus Life Table Characteristics 
and Vector Competence for Dengue Virus 
*Note: This chapter is formatted as a complete manuscript and will be submitted to a peer-
reviewed journal in the future. Hence, there may be some repetition in Chapter 2 (Literature 
Review) and the Introduction for Chapter 4. 
Abstract 
 Commercially available blood can be used as an alternative to live animals to maintain 
mosquito colonies and deliver infectious blood meals during research studies. However, the 
extent to which artificially delivered blood sources affect mosquito life table characteristics of 
Aedes albopictus and vector competence for dengue virus (DENV) is unknown. Consequently, 
we analyzed the extent to which two blood sources affected life table characteristics (i.e. 
fecundity, fertility, hatch rate, adult survival) and vector competence (infection, dissemination, 
transmission) of Ae. albopictus for DENV. Two types of blood (N = 40 mosquitoes/group) were 
tested at two extrinsic incubation temperatures for DENV-infected and –uninfected mosquitoes 
as follows:  1) defibrinated, 27°C; 2) citrate, 27°C; 3) defibrinated, 30°C; 4) citrate, 30°C. Fully 
engorged mosquitoes were transferred to individual cages containing an oviposition cup and 
substrate. The presence of eggs was observed daily and, if eggs were observed, the substrate was 
removed and the number of eggs was counted (fecundity) for each female. Eggs were allowed to 
hatch and larvae were counted (fertility) for each female. At 14 and 21 days post feeding, 15 
mosquitoes were taken from each group and tested for DENV in bodies (infection), legs 
(dissemination), and saliva (transmission). Mosquitoes fed DENV-infected defibrinated blood 
showed significantly higher DENV body titer (P = 0.034) and fecundity (P = 0.032), as well as 
faster hatch time (P = 0.039) compared to mosquitoes fed DENV-infected citrated blood. 
Temperatures tested here did not (P > 0.05) affect any factor measured. No differences were 
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observed in DENV leg titers between treatments. DENV transmission was observed in all groups 
14 days post infection and was observed in all but the 30°C defibrinated blood group at the 21 
day post infection time point. Infected mosquitoes showed higher fecundity than uninfected 
mosquitoes (P = 0.001); however, fertility was lower in infected compared to uninfected 
mosquitoes (P = 0.001). Eggs of DENV-infected mosquitoes hatched faster than the uninfected 
groups (P = 0.005). We expect the findings of this study to improve methods for mosquito 
colony propagation and inform research using artificial blood delivery methods to assess vector 
competence.  
Introduction 
Aedes albopictus Skuse is an anthropophilic mosquito that was first detected in the 
United States (US) in Houston, Texas in 1985 in a shipment of tires from Asia (Hawley et al., 
1987; Moore and Mitchell, 1997; Gubler, 2002; Alto and Bettinardi, 2013) and has since spread 
to > 678 counties in ca. 25 states (Hawley et al., 1987; Moore and Mitchell, 1997; CDC, 2014). 
Aedes albopictus is the most invasive mosquito species in the world and has significant public 
health importance due to its ability to transmit multiple pathogens including West Nile virus, La 
Crosse virus and dengue virus (DENV, family Flaviviridae, genus Flavivirus) (Benedict et al., 
2007).  
 In the US, each person hospitalized from DEN pays approximately $17,803 and less 
severe cases cost ca. $1,610 (Shepard, 2011). The median cost of treatment throughout Pan 
America is $1,227 (Shephard, 2011). A study reports the economic cost of DEN cases in the 
Philippines in 2012 was $345 million ($3.26 per capita), a 54% increase from 2010 (Edillo et al., 
2015). For laboratories studying DEN and other infectious diseases, mosquito colonies are 
maintained with blood (either live animals or artificial delivery systems) (Clements, 1992). One 
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environmental factor that affects biological processes of mosquitoes (including their interaction 
with viruses and survival) is temperature (Halsted, 2008; Alto and Bettinardi, 2013; Brady et al., 
2013; Carrington et al., 2013). Survival of the vector is a key component of transmission of a 
vector-borne pathogen (Reisen et al., 1980). Increased survival time allows the vector more 
opportunities to produce offspring, disperse, and, transmit pathogens in subsequent blood 
feedings (Brady et al., 2013; Parham and Michael, 2010; Barbazan et al., 2010). Under 
laboratory conditions, the effects of temperature can be quantified and other causes of mortality 
found in the field such as predation or disease are removed (Brady et al., 2013). Laboratory 
conditions are not expected to produce the same effects on life table characteristics as field 
conditions (Lambrechts et al., 2011; Brady et al., 2013), but are often used as a proxy for 
understanding aspects of field dynamics. Vector competence includes the mosquito’s 
susceptibility to infection and the capacity to transmit a pathogen to a host after ingestion of an 
infectious blood meal (Kramer and Ebel, 2003; Salazar et al., 2007; Carrington et al., 2013). A 
previous study of Ae. aegypti describes how females exposed to a large diurnal temperature 
range ca. 20°C mean showed a higher rate of DENV dissemination after 28 days compared to 
females reared under a constant controlled temperature (dissemination rates of 100% vs. 42%, 
respectively) (Carrington et al., 2013). Increases in extrinsic incubation temperatures have been 
associated with enhanced vector competence in several vector-virus systems (e.g. Richards et al., 
2007; Richards et al., 2009; Kilpatrick et al., 2008).  
For many laboratories, commercially available blood is used as an alternative to live 
animals when feeding mosquitoes. It replaces the time required to maintain live animals which 
are expensive to keep and subject to government regulation (Turell, 1988). However, 
laboratories that employ artificial blood delivery systems must also consider the effect of the 
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blood source on the life table characteristics (and possibly vector competence) of the mosquitoes 
(Richards et al., 2012). This must also be considered when comparing results of experiments 
where different types of blood are used. Blood can be treated with anticlotting additives such as 
sodium citrate and/or go through defibrination (e.g. fibrin separated from it during the clotting 
process) to prevent coagulation. Experimental results may be influenced if there are 
physiological changes that manifested in the mosquitoes from using different blood sources 
(Richards et al., 2012).  
Previous research has assessed the effects of blood meal source on life table 
characteristics of Culex pipiens quinquefasciatus (Richards et al., 2012), Culex theileri (Demirci 
et al., 2014), Ae. aegypti (Bennett, 1970; Watts et al., 1987) and five Anopheles species 
(Phasomkusolsil, 2013). Previous studies have also looked at the effects of extrinsic incubation 
temperature (EIT) on vector competence in Culex nigripalpus for Saint Louis encephalitis virus 
(Richards et al., 2012), Culex pipiens quinquefasciatus for Saint Louis encephalitis virus 
(Richards et al., 2009), West Nile virus (Richards et al., 2007) and on Ae. albopictus (Richards et 
al., 2012) and Ae. aegypti for DENV (Watts et al., 1987). The aim of the current study is to 
improve mosquito colony propagation techniques and to inform future research using artificial 
blood delivery methods and different EITs to assess vector competence and life table 
characteristics of Ae. albopictus. No studies have assessed the effects of blood source on life 
table and vector competence characteristics for Ae. albopictus infected with DENV.  
Materials and Methods 
Mosquitoes and Virus  
Ae. albopictus eggs (F8) originating from New Orleans, Louisiana were reared at 27°C 
under standard conditions to produce similar sized mosquitoes (Richards et al. 2009) with 70-
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80% relative humidity and a 14:10 (light:dark) cycle. Eggs on seed germination paper were 
placed in 16 plastic pans (34.3 cm x 25.4 cm) (Bioquip, Rancho Dominguez, CA) with 
approximately 1200 mL of tap water/pan. Larvae were fed a 2:1 mixture of Brewer’s yeast and 
liver powder each day. Pupae were transferred to 200 mL plastic cups containing approximately 
150 mL of tap water, placed into square cages (30.5 cm height x 30.5 cm width x 30.5 cm depth) 
(Bioquip, Rancho Dominguez, CA), and provided 20% sucrose ad libitum. Plastic cups 
containing pupae were removed after three days to limit the age difference of adults. A Southeast 
Asian DENV-2 (16803 strain) was passaged once in the mosquito Toxorhynchites amboinensis 
Doleschal, twelve times in Vero cells and twice in C6/36 cells.  
Blood Meal Preparation and Infection Study 
A T-75 flask containing a monolayer of African green monkey kidney (Vero) cells was 
inoculated with 0.15 mL DENV. Next, 12 mL of Medium 199 with Earle’s salts (M199E), 
penicillin/streptomycin, fungizone, and fetal bovine serum (FBS) was added to the flask and 
incubated at 35°C with 5% CO2 for six days. A 1:1 ratio of DENV supernatant and either citrated 
or defibrinated bovine blood (warmed to 35°C for 10 minutes) was mixed and blood soaked 
cotton balls were used to deliver blood meals to mosquitoes. Mosquitoes in the uninfected 
groups received a 1:1 ratio of M199E:uninfected citrated or defibrinated blood.  
Twenty-four hours prior to blood feeding, sucrose was removed from mosquito cages and 
replaced with water in order to encourage blood feeding. Figure 10 shows the study design where 
ca. 1,000 female Ae. albopictus were used to account for an expected 35% feeding rate. 
Mosquitoes were allowed to feed for 45 minutes and categorized in the following groups: 1) 
DENV-infected defibrinated blood, EIT 27°C (ID27), 2) DENV-infected defibrinated blood, EIT 
30°C (ID30), 3) DENV-infected citrated blood, EIT 27°C (IC27), 4) DENV-infected citrated 
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blood, EIT 30°C (IC30), 5) uninfected defibrinated blood, EIT 27°C (UD27), 6) uninfected 
defibrinated, EIT 30°C (UD30), 7) uninfected citrated blood, EIT 27°C (UC27), 8) uninfected 
citrated blood, EIT 30°C (UC30) (Figure 10). We observed ca. 37% feeding rate in all groups, 
with no difference between citrated and defibrinated groups. We collected 0.1 mL of each blood 
meal (placed in 2 mL microcentrifuge tubes with 0.9 mL of M199E media) for later analysis to 
determine blood meal DENV titer. Five freshly fed mosquitoes/group were collected to 
determine the amount of virus imbibed by mosquitoes. All samples were stored at -70°C until 
subsequent testing. After blood feeding, mosquitoes were immobilized with cold and fully 
engorged specimens were transferred individually to separate 0.5 L cardboard cages containing a 
black oviposition cup (60 mL) glued to the bottom of the cage, a second (clear) oviposition cup 
placed inside the black oviposition cup, and a 2.5 cm x 2.5 cm oviposition substrate (seed 
germination paper) clipped to the side of the clear cup. The second clear cup was used to 
facilitate removal and counting of the eggs during later processing (unpublished data). Partially 
fed and unfed mosquitoes were discarded. Mosquitoes were provided 20% sugar ad libitum. 
Mosquito survival was monitored daily for the duration of the experiment. As mosquitoes in the 
infected group died, they were placed (within 24 h of death) in individual 2 mL microcentrifuge 
tubes with 0.9 mL of M199E media and 2 stainless steel BBs and stored at -70°C until 
subsequent testing for virus titer. 
Three days post-blood feeding, 25 mL of tap water was added to each ovicup so that the 
oviposition substrate was moistened. The presence of eggs was assessed daily by visual 
inspection. Two days after eggs were observed, the corresponding mosquito was aspirated from 
the container, the clear oviposition cup was removed, and the eggs on the oviposition strip and 
floating in the cup were counted (fecundity) using a dissecting microscope. Egg strips were 
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submerged in the water contained in the respective oviposition cup, along with larval food 
administered ad libitum. Oviposition cups were returned to incubators and eggs allowed to hatch. 
The date eggs hatched was recorded for each cage. Approximately seven days post-hatching, all 
larvae were counted (fertility) using a dissecting microscope. Larvae hatching from eggs of adult 
females from the uninfected group were counted and sacrificed. Larvae hatching from eggs of 
DENV-infected adult females were counted and allowed to reach adulthood. Adult females and 
males from each brood in the DENV-infected group were pooled by cage (brood of a single 
female) and frozen (-70°C) for future testing of transovarial DENV transmission. 
At 14 and 21 days post blood feeding, 15 mosquitoes were aspirated from each infected 
treatment group. Mosquitoes were chilled, wings removed, and legs transferred to micro-
centrifuge tubes containing 0.9 mL M199E, penicillin/streptomycin, fungizone, FBS, with two 
stainless steel BBs. Live mosquito bodies were secured to a glass surface and separate capillary 
tubes containing ca. 20 uL FBS were placed over each proboscis following standard methods 
(Anderson et al., 2010; Richards et al., 2012). After mosquitoes were allowed to salivate for 45 
minutes, capillary tubes were removed and the contents were expelled into separate tubes 
containing 0.9 mL M199E media with two BBs. Then the bodies were placed in a third 
corresponding tube so that each mosquito had three tubes (infection [body], dissemination [legs], 
transmission [saliva]).  
Processing Samples 
Samples were processed using previously established methods (Richards et al., 2007). 
Mosquito samples were homogenized using a TissueLyser II (Qiagen, Valencia, California) for 
three minutes at 25 Hz. Samples were then centrifuged (4°C) at 4000 RPM for four minutes. 
Nucleic acids were isolated from 0.14 mL of samples using the QIAamp Viral RNA Mini Kit 
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(Qiagen, Valencia, California) following the manufacturer’s protocol. The amount of viral RNA 
(calculated in plaque forming unit equivalents; PFUeq) in each sample was determined using 
TaqMan quantitative real-time reverse transcriptase polymerase chain reaction (qRT-PCR) with 
the LightCycler® 480 Instrument (Roche, Basel, Switzerland) and the Superscript III One-Step 
qRT-PCR kit (Invitrogen, Carlsbad, CA) using a program previously established by Richards et 
al. (2007). Samples were amplified as follows - DENV-2 samples: 48oC for 30 min, 95oC for 2 
min, 45 cycles at 95oC for 15 s and 60oC for 30 s, and finally 40oC for 30 s. Dengue virus primer 
and probe (FAM dye with black hole quencher) sequences used to identify the capsid genomic 
region are as follows: Forward primer:  CAT GGC CCT KGT GGC G (237-251); reverse 
primer:  CCC CAT CTY TTC AGT ATC CCT G (305-284); probe:  TCC TTC GTT TCC TAA 
CAA TCC (254-274) (Callahan et al. 2001). 
Statistical Analyses  
Variables analyzed are listed in Table 3. Analysis of variance (ANOVA; P < 0.05) (IBM 
SPSS version 20, Armonk, New York) was used to determine differences in rates of 1) fecundity, 
2) fertility, 3) oviposition rate, and 4) hatch time between different types of blood (citrated or 
defibrinated) and EITs (27°C or 30°C) (Table 4). We further analyzed (ANOVA) differences in 
these four variables between mosquitoes fed uninfected or infected blood (Table 5). The 
differences in, 1) infection rate, 2) dissemination rate, 3) horizontal transmission rate 4) 
transovarial transmission rate, 5) body titer, 6) leg titer, and 7) saliva titer were analyzed using 
ANOVA for mosquitoes at 14 and 21 days post blood feeding (Table 6). The effects of blood 
meal type and status of infection on the lifespan of adult females was ascertained using non-
parametric survival analysis and Kaplan Meier tests (P < 0.05). 
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Results 
Blood Meal Titer 
 Blood meals containing infected defibrinated bovine blood showed 7.4 ± 0.3 log10 PFUe 
DENV/mL and infected citrated bovine blood showed 7.3 ± 0.1 log10 PFUe DENV/mL. No 
significant difference was observed in blood meal titers between types of blood (F = 0.092, P 
=0.795, df =1,1).  
Effects of Blood Source and EIT on Life Table Characteristics 
Mosquitoes fed uninfected citrated bovine blood had significantly higher fecundity 
compared to those fed uninfected defibrinated bovine blood (Table 4, Figure 11). Fertility was 
also significantly higher in the uninfected citrated group than in the uninfected defibrinated 
group (Table 4, Figure 12). Mosquitoes fed uninfected blood (citrated or defibrinated) and 
incubated at 30°C had a significantly faster hatch time compared to mosquitoes fed uninfected 
blood and incubated at 27°C, but no differences were observed in fecundity, fertility or 
oviposition time between blood types and EITs (Table 4, Figures 11-14). Blood meal source 
(regardless of EIT) did not affect oviposition time or hatch time in mosquitoes fed uninfected 
blood (Figures 13 and 14). Mosquitoes in the uninfected group fed different sources of blood and 
incubated at different EITs (blood source * EIT) showed no significant differences in life table 
characteristics (Table 4). 
Mosquitoes in the DENV-infected group fed defibrinated blood exhibited significantly 
faster oviposition time than DENV-infected mosquitoes fed citrated blood, but showed no 
significant differences in fecundity, fertility or hatch time between different blood sources or 
EITs (Table 4, Figures 11-14). Effects of blood source on life table characteristics in DENV-
infected mosquitoes did not change with EIT (blood source * EIT)  (Table 4).  
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Effects of Blood Source and EIT on Vector Competence 
 
Infection rate was 100% for mosquitoes sampled at both 14 and 21 days post-blood 
feeding (Figures 15 and 16). No significant differences were found in dissemination rates 
between blood type and EIT for either the 14 or 21 day incubation period (Table 6; Figures 15 
and 16). At the 21 day incubation period (but not for the 14 day incubation period), horizontal 
transmission rate was significantly higher in mosquitoes fed citrated blood (Table 6); however, 
mosquitoes in the 21 day group fed defibrinated blood and incubated at 30°C did not show any 
horizontal transmission. Consequently, statistical tests could not be conducted for the interaction 
effects between blood source and EIT on horizontal transmission. Vertical (transovarial) 
transmission was not found in any group.  
Effects of Infection Status on Life Table Characteristics 
 At 14 days post infection (dpi), body DENV titers were significantly higher in 
mosquitoes fed defibrinated blood (7.4 ± 0.09 PFUe DENV/mL) compared to citrated blood (7.0 
± 0.05 PFUe DENV/mL) (Table 6, Figure 15). At 14 dpi, no significant differences were 
observed in leg titers between mosquitoes fed citrated or defibrinated blood, but saliva titers 
were significantly higher in the citrated group (Table 6, Figure 15). At 21 dpi, body, leg and 
saliva titers were not affected by blood source, EIT or blood source * EIT (Table 6; Figure 16). 
Significantly higher body (P = 0.000), leg (P = 0.000) and saliva (P = 0.000) titers were 
observed at the 14 day compared to the 21 day time point (Figures 17-18). 
Fecundity was significantly higher in mosquitoes in the infected group compared to 
uninfected mosquitoes (Figure 11, Table 4). Blood source and infection status significantly 
increased fecundity (Figure 11, Table 6). Fertility was not significantly affected by blood source  
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(Figure 12, Table 4). Oviposition time was significantly faster in the citrated group among both 
infected and uninfected mosquitoes (Figure 13, Table 4). Hatch time was significantly faster in 
mosquitoes in the infected group compared to the uninfected group (Figure 14, Table 4).  
Mosquito Survival 
At both 27°C and 30°C, mosquito survival was significantly lower in the infected group 
(P = 0.046 and P = 0.011, respectively) compared to the uninfected group (Figures 19 and 20, 
Table 7). Blood source and EIT did not affect survival among infected or uninfected groups 
(Figures 19 and 20). In the 27°C group, the uninfected groups experienced ≥ 80% survival. 
However, both infected citrate and infected defibrinated groups experienced a dramatic drop in 
survival after two days post blood meal and this decline in survival levelled off at eight days post 
blood meal. In the 30°C group the infected citrated group experienced the lowest survival rate 
with only 40% surviving to 21 days post blood meal, while the infected defibrinated group 
experienced 81% survival, similar to the uninfected citrate group at 83%. The 30°C uninfected 
defibrinated group experienced 62% survival. As with the 27°C group (not including the infected 
citrated group which levelled off after day 14) the survival rate decreased after 2 days post blood 
meal and levelled off after seven days post blood meal. To account for the skewed curve that 
would appear if mosquitoes purposefully taken at 14 dpi were present, we excluded them from 
the survival curve.  
Discussion  
The interactions between vectors and viruses are complex and can be affected by both 
environmental and biological factors. In the current study, defibrinated bovine blood and citrated 
bovine blood impacted Ae. albopictus life table characteristics (i.e. fecundity, fertility, 
oviposition time, hatch time, infection rate, dissemination rate, and horizontal transmission rate) 
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with mosquitoes fed citrated blood exhibiting higher fertility and fecundity. The higher EIT 
tested here (30°C) was associated with increased (+ 11%) fertility in groups fed citrated blood 
and decreased hatch time in the uninfected group, but did not affect fecundity or oviposition time 
in any group. Temperatures tested here did not affect adult survivorship in any group. We show 
that EITs of 27°C and 30°C did not affect infection or dissemination rates in Ae. albopictus fed 
either DENV-infected defibrinated or citrated blood, but did affect horizontal transmission. 
Horizontal transmission was significantly lower in the 30°C group, regardless of blood source. 
Alto and Bettinardi (2013) evaluated Ae. albopictus fed defibrinated bovine blood containing 7.1 
± 0.14 log10 PFU DENV/ml and incubated at 20°C, 25°C, or 30°C. The same study showed that 
EIT did not affect Ae. albopictus susceptibility to infection with DENV at 14 and 21 days post 
blood meal at 25°C or 30°C. However, a significant difference in dissemination was observed in 
all groups at 25°C compared to the 30°C treatment group, although the aforementioned study did 
not test transmission. Vertical (transovarial) transmission was not observed in our study, but has 
been well documented in the past under varying conditions (Rosen, 1988; Lee et al., 1997; Joshi 
et al., 2002; Lee and Rohani, 2005; Buckner et al., 2013). The lack of transovarial transmission 
we observed could be due to low mosquito body titers at the time of oviposition.  
In a previous study using Ae. aegypti fed DENV blood meals and incubated at a standard 
temperature of 26°C with daily diurnal temperature fluctuations of 0°C, 10°C and 20°C, DENV 
dissemination and transmission occurred within a week or less (Lambrechts et al., 2011). In 
another study performed using Ae. aegypti housed at (26°C, 28°C and 30°C) and fed blood 
meals containing DENV- 2 and -4, the extrinsic incubation period (EIP) was decreased from nine 
days to five days between the 26°C group to the 30°C group (Rohani et al., 2004). Temperatures 
≥ 35°C, are detrimental to mosquitoes, causing inhibited development, increased mortality, and 
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impairment of reproductive function (Rohani et al., 2004; Carrington et al., 2013; Carrington et 
al., 2013). Up to a point, higher EITs facilitate DENV transmission because the virus propagates 
and disseminates faster within the vector (Carrington et al., 2013). Anderson and Rico-Hesse 
(2006) determined that mosquitoes fed simultaneously on both the American and Southeast 
Asian DENV-2 genotypes were more likely to become infected with the Southeast Asian (21% 
of mosquitoes) compared to American (3% of mosquitoes) genotype (Anderson and Rico-Hesse, 
2006). McAllen (Texas) Ae. aegypti females were reared at 28˚C with 75% humidity and a 14:10 
light/dark cycle (Anderson, 2006). The blood meal contained defibrinated rabbit blood and either 
the Southeast Asian or American strain of DENV-2 virus at 2.5 x 108 genome equivalents/mL. 
After feeding, mosquitoes were incubated at 30˚C for up to 14 days (Anderson and Rico-Hesse, 
2006). In the same study, by day four post infection, 80% of midguts were positive with 
Southeast Asian genotype compared to 45% infected with the American genotype. The same 
occurred with the salivary glands where at day seven post blood feeding, 50% of the mosquitoes 
fed the Southeast Asian strain were virus-positive, while it took until day 14 post-infection for 
the American strain to reach 50% infection. It was determined that the Southeast Asian strain 
replicated to a higher level than did the American strain (Anderson, 2006). 
The time required for the EIP of DENV is eight to 14 days (Axford et al., 2011; Miranda 
and Johansson, 2012; Goncalves et al., 2014). Our findings that mosquitoes at 21 days post blood 
feeding had significantly lower body, leg, and saliva titers compared to 14 day time point concur 
with Salazar et al. (2007) using Aedes aegypti mosquitoes. The same study showed that viral 
titers decreased significantly at 14 and 21 days compared to seven days post infection (Salazar et 
al., 2007). Several studies look at earlier points in EIP [e.g. Chan and Johansson (2012); Alto et 
al. (2014)] and have shown that viral titers were highest 7-10 days post infection.  
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We found significant differences in fertility and fecundity in uninfected groups fed 
different sources of blood with mosquitoes feeding on citrated blood laying ca. 11 more eggs per 
female (fecundity) and fertility increasing by 14% compared to uninfected mosquitoes feeding 
on defibrinated blood. Significant differences in oviposition time and hatch time were also found 
in the infected groups. Oviposition time was faster and decreased by 1.2 days in mosquitoes fed 
infected defibrinated blood compared to infected citrated blood. Hatch time was also faster and 
decreased by 0.9 days in the infected group compared to the uninfected group. Body titers were 
also significantly higher in mosquitoes fed infected defibrinated compared to citrated blood, but 
leg and saliva titers were not significantly affected by blood source. Host blood sources affect the 
duration of the gonotrophic cycle and fecundity in Ae. triseriatus (Mather and DeFoliart, 1983). 
The same study found that Ae. triseriatus fed blood from white-tailed deer had significantly 
shorter gonotrophic cycles, while mosquitoes fed blood from squirrels and chipmunks needed a 
longer time to complete their gonotrophic cycle. However, Ae. triseriatus fed blood from 
squirrels and chipmunks experienced significantly higher fecundity than Ae. triseriatus fed blood 
from white-tailed deer (Mather and DeFoliart, 1983).  
Mahmood et al (2004) fed Culex tarsalis heparinized chicken blood (heparin sodium 
added to the blood to prevent coagulation) with 6 log10 PFU Western equine encephalitis virus 
(WEEV)/ml for one group and 4 log10 PFU WEEV/ml for the other group. The same study 
incubated mosquitoes at 26°C. Findings indicate fecundity was significantly lower in the WEEV 
infected group (133 and 134 eggs/female in the 6 log10 PFU/ml and 4 log10 PFU/ml respectively 
versus 213 eggs/female in the uninfected group); however, fertility was significantly higher in 
the WEEV infected groups (Mahmood et al., 2004). A study performed by Richards et al. (2010) 
looked at the effects of blood meal source (live chicken, chicken blood in Alsever’s [AC] 
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solution, defibrinated bovine blood, and citrated bovine blood) on the reproduction of Culex 
pipiens quinquefasciatus (Diptera:  Culicidae) at  28°C. Results show Cx. p. quinquefasciatus fed 
AC exhibited significantly higher fecundity during the first blood feeding when compared with 
all other groups (Richards et al., 2010). The fastest hatch times were found in the groups fed live 
chicken blood or AC (Richards et al., 2010). In the same study, Cx. p. quinquefasciatus fed 
defibrinated bovine blood and citrated bovine blood experience the lowest fecundity and fertility 
in the first blood feeding (Richards et al., 2010). Scientists should consider that different blood 
sources could affect colony propagation and estimates of vector competence. This knowledge is 
important to improve laboratory studies evaluating risk of mosquito populations for virus 
transmission. We expect the findings of this study to improve methods for mosquito colony 
propagation and inform research using artificial blood delivery methods to assess vector 
competence.   
 
 
Chapter 5 – Conclusion 
Little research has been performed on the Pan American expansion of DEN over the past 
decade and the increase of international travel has aided its status as the most prevalent vector 
borne disease in humans. As range expansion of vectors and international travel continues to 
increase, DEN epidemics will continue to occur. The US is at risk of DENV establishment due to 
international travel, climate change, and presence of competent vectors (Moore and Mitchell, 
1997; MMRW, 2010; WHO, 2012). The current lack of serological testing, standardized 
diagnoses, and efficient reporting systems impede DEN risk assessment (Gubler, 2002; Guzman, 
2003; Gubler 2012). These increased risks are important to public health due to the economic 
burden of lost work time and associated medical costs (MMWR, 2010; Rothman, 2013, Gubler 
1998). The geographic ranges of the four DENV serotypes are expected to expand with 
international travel as humans are the primary reservoirs (Gubler, 2012). This increases the 
likelihood of multi-serotype epidemics that could impact public health. Risk assessments 
showing the impact of travel on importation of DENV are essential to understand the role of 
human travel in pathogen spread. 
Laboratory vector competence studies should consider methodological differences, such 
as blood source, that may impact estimates of vectorial capacity. No previous study has 
examined the effects of blood meal source and EIT on life table characteristics and vector 
competence for DENV in Ae. albopictus. While studies on the effects of EIT Culex spp. infected 
with WNV and SLEV show increases in vector competence at higher EITs (Richards et al., 
2007; Richards et al., 2012), a study on Ae. albopictus has shown that EIT had no effect on 
DENV vector competence when comparing effects on virus titers (Alto and Bettinardi 2013). 
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Alto and Bettinardi (2013) show similar findings at 20°C, 25°C and 30°C compared to our 
results for infection and dissemination at 27°C and 30°C.  
Artificial blood delivery systems are often used to propagate mosquito colonies as this 
method is cost effective compared to maintaining live animals (Turell, 1988; Richards et al., 
2012). Commercially available blood also replaces the time required to maintain live animals 
which are expensive to keep and subject to government regulation (Turell, 1988). However, 
laboratories that employ artificial blood delivery systems must also consider the effect of the 
blood source on the life table characteristics (and possibly vector competence) of the mosquitoes 
(Richards et al., 2012). Future studies with additional EITs, mosquito populations and species, 
and blood meal sources will contribute to the overall knowledge of mosquito colony propagation 
and studies determining transmission risk.
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Appendix 
Table 1. Serologically Positive Cases of Dengue in 52 Pan American Countries from 2001-2012 
  2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 
N
o
rt
h
 
A
m
er
ic
a Canada NA NA NA NA NA NA NA NA NA NA NA NA 
United 
States 
96 29 40 10 98 143 488 199 178 648 283 545 
C
en
tr
al
 A
m
er
ic
a 
Belize 3 41 NA 2 380 9 40 23 1457 2178 469 1948 
Costa Rica 9237 12251 19669 9408 37798 12124 26440 7160 6946 31773 13854 22243 
El Salvador 1093 18307 7436 13344 15290 22088 12476 5774 15040 22406 20836 41793 
Guatemala 4516 7599 6750 6352 6341 2428 5886 3230 10438 17045 2565 9547 
Honduras 9077 32269 16559 19971 18843 8436 33508 18941 15291 66814 8297 15554 
Mexico 6210 9844 5018 8202 16862 27287 48436 31154 249763 57971 67918 164947 
Nicaragua 2104 2157 2799 1035 1735 1350 1415 1424 17140 6261 11888 30499 
Panama 1545 711 293 373 4000 4300 3402 2287 6811 1243 3882 1329 
S
o
u
th
 A
m
er
ic
a 
Argentina 11 214 135 3284 34 181 173 40 26612 1185 213 2043 
Bolivia 176 892 6548 7390 4443 2040 7332 3181 84047 5191 26681 42704 
Brazil 416067 780644 341902 112928 203789 346550 559954 734384 528883 1004392 764032 565510 
Chile (Only 
Easter 
Island) 
 636 NA NA NA 3 28 25 27 NA 1 34 
Colombia 55437 76996 52588 27523 30475 36471 43227 26732 51543 157152 33207 49361 
French 
Guiana 
2830 280 2178 3147 4365 15930 661 460 11330 4350 667 1372 
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Guyana 60 202 33 47 178 118 201 324 994 1468 1093 2189 
Ecuador 10919 5833 10319 6165 12131 6044 10587 1894 4489 1042 7659 18995 
Paraguay 38 1871 137 164 405 4271 28182 1953 6143 13553 42945 33063 
Peru 23329 8875 3637 9774 6358 5531 6907 10278 8813 18392 29810 29994 
Suriname 760 1104 285 375 2853 285 41 24 120 113 409 781 
Uruguay NA NA NA NA NA NA NA NA NA NA NA NA 
Venezuela 83180 37676 26996 30693 42198 39860 80646 48048 65869 123967 31551 49044 
C
ar
ib
b
ea
n
 
Cuba 11432 3011 NA NA 75 NA 28 NA 70 NA NA NA 
Dominican 
Republic 
3592 3194 6163 2476 2860 6143 9628 4333 8292 11519 2339 9665 
Puerto Rico 5233 2906 3735 3288 5701 3043 11012 3384 6651 21298 5654 12877 
American 
Virgin 
Islands 
NA NA NA NA NA NA 73 NA NA NA 
NA NA 
Anguilla 25 5 2 NA NA NA NA 9 NA 1 9 9 
Antigua 
and 
Barbuda 
20 5 NA NA NA NA NA 17 NA 3 
7 
10 
Aruba NA 25 NA 173 NA 5 NA NA 845 1415 3027 667 
Bahamas NA NA 180 1 NA NA NA 1 NA 8 7000 5 
Barbados 1043 740 557 349 320 1 NA 1 55 2917 745 1445 
Bermuda NA NA NA NA 2 2 NA NA NA 2 1 NA 
British 
Virgin 
Islands 
23 NA NA NA 1 NA 6 15 65 9 939 214 
Cayman 
Islands 
NA 1 1 NA 1 NA 9 1 NA 8 2 53 
Curacao NA NA NA NA 265 NA NA NA NA 1723 1555 721 
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Dominica 5 NA NA 4 11 19 111 80 2 635 40 29 
Grenada 12 84 17 7 NA 22 NA 6 23 125 87 75 
Guadaloupe NA 93 495  3364 2948 3266 2234 2234 41100 824 
1032 
Haiti NA NA NA NA NA NA NA NA NA NA NA 240 
Jamaica 39 90 52 9 46 79 1448 359 70 2827 408 4670 
Martinique 4471 392 791 NA 6083 4086 5082 586 1378 37100 275 1269 
Montserrat 1 1 1 NA NA NA NA 2 NA NA 3 
1 
Netherlands 
Antilles 
NA NA NA NA NA NA NA NA NA 
852 939 121 
St. 
Bartolome 
NA NA NA NA NA NA NA NA 805 NA 
23 32 
St. Kitts & 
Nevis 
89 20 2 4 NA 1 NA 49 2 19 47 1 
St. Lucia 292 51 5 11 1 NA 39 98 18 74 585 33 
St. Martin NA NA NA NA NA NA NA NA 1698 2450 168 253 
St. Vincent 
and the 
Grenadines 
3 125 3 4 8 5 2 6 10 133 47 193 
Trinidad & 
Tobago 
2244 6246 2289 546 411 37 47 2366 24 2497 1243 
2473 
Turks & 
Caicos 
Islands 
NA NA 2 1 1 
NA NA NA NA NA 
24 16 
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Table 2: Serologically Positive Cases of Dengue in 18 Pan American Countries from 2001-2012* 
World 
Rank 
Pan 
American 
Rank 
Country 
Name 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 
1 1 Canada 0 0 0 0 0 0 0 0 0 0 0 0 
2 2 Mexico   1,2,3   1,2,3,4 1,2,3 1 1,2,3,4 1,2,3 1,2,3,4 1,2,3 1,2,3,4 1,2,3,4 
7 3 Brazil 1,2,3 1,2,3 1,2,3 1,2,3 1,2,3 1,2,3 1,2,3 1,2,3 1,2,3 1,2,3,4 1,2,3,4 1,2,3,4 
15 4 Venezuela 1,2,3,4 2,3,4 1,2,3 1,2,3,4 1,2,3,4 1,2,3,4 1,2,3,4 1,2,3,4 1,2,3,4 1,2,3,4 1,2,3,4 1,2,3,4 
16 5 Columbia 1,2,4 1,3,4 1,2,3 1,2,3,4 1,2,3,4 1,2,3,4 1,2,3,4 1,2,3,4 1,2,3 1,2,3,4     
18 6 Argentina   1,3 1,2,3 3 2 2,3 2,3 1 1 1,2,3   2,3 
25 7 
Dominican 
Republic 
  2 2 2,4   1,2 1,2,3,4   1,2,4 1,2,4 2 2 
26 8 Bahamas     2,4             1,2 1   
28 9 Guatemala 2,4 2,3,4 1,2,3,4 1,2,3,4 1,2,3,4 1,2,4 1,2,4 1,2 2,4 1,2,3,4 1,2 1,2,3 
29 10 Jamaica             2,4 3   2     
31 11 Ecuador 1,2 1,2,3 3 3 2 3 3   1,3 1,2,3 1,2 2,4 
33 12 Peru 1,2,3,4 1,3 1,2,3 1,2,3 1,2,3,4 3 1,2,3,4 1,3,4 1,2,3,4 1,2,3,4 1,2,3,4 1,2,3,4 
34 13 Costa Rica 2 1,2 1,2 1,2 1 1,2 1 1,2 1,2 1,2,3 1,2,3 1,2,3 
36 14 
Trinidad 
and 
Tobago 
2,3 2,3 3   2,3 2,3 3 2,3 2 2 1,4 
  
38 15 Chile   1         1 1 1,4   1   
39 16 
El 
Salvador 
2 1,2,3,4 2,4 1,2,4 2,4 1,2,4 1,2   1,2,3,4 1,2 1,2,3,4 1,2,3 
41 17 Honduras 2,3,4 2,4 1,2,4 1,2,4 1,2,4   1,2,4 2,4 1,2 1,2,3,4 1,2 1,2 
44 18 Panama 2 2 2 1,2,3 1,2   3 3 1,3 1,3 1,2,3 1,2,3 
*Note: Of the top 50 countries in the world that travel to the US, 18 are from Pan America. This table shows those 18 countries.
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Table 3: Description of Variables  
Variable Calculations 
Fecundity = 𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑒𝑔𝑔𝑠 𝑙𝑎𝑖𝑑 𝑝𝑒𝑟 𝑓𝑒𝑚𝑎𝑙𝑒 
Fertility = 
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑒𝑔𝑔𝑠 ℎ𝑎𝑡𝑐ℎ𝑒𝑑 𝑝𝑒𝑟 𝑓𝑒𝑚𝑎𝑙𝑒
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑒𝑔𝑔𝑠 𝑙𝑎𝑖𝑑 𝑝𝑒𝑟 𝑓𝑒𝑚𝑎𝑙𝑒
   
Oviposition Time =Mean number of days to oviposit 
                                    Hatch Time = M𝑒𝑎𝑛 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑑𝑎𝑦𝑠 𝑡𝑜 ℎ𝑎𝑡𝑐ℎ 
Infection Rate = 
# 𝑤𝑖𝑡ℎ 𝐷𝐸𝑁𝑉−𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑏𝑜𝑑𝑖𝑒𝑠
# 𝑜𝑓 𝑏𝑙𝑜𝑜𝑑 𝑓𝑒𝑑 𝑚𝑜𝑠𝑞𝑢𝑖𝑡𝑜𝑒𝑠
 
Dissemination Rate = 
# 𝑤𝑖𝑡ℎ 𝐷𝐸𝑁𝑉−𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑙𝑒𝑔𝑠
# 𝑤𝑖𝑡ℎ 𝐷𝐸𝑁𝑉 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑏𝑜𝑑𝑖𝑒𝑠
 
Horizontal Transmission Rate = 
# 𝑤𝑖𝑡ℎ 𝐷𝐸𝑁𝑉 −𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑠𝑎𝑙𝑖𝑣𝑎
# 𝑤𝑖𝑡ℎ 𝐷𝐸𝑁𝑉 −𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑏𝑜𝑑𝑖𝑒𝑠
 
Transovarial Transmission Rate = 
# 𝑜𝑓 𝐷𝐸𝑁𝑉 − 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑝𝑜𝑜𝑙𝑠 𝑜𝑓 𝑜𝑓𝑓𝑠𝑝𝑟𝑖𝑛𝑔
# 𝑜𝑓 𝑝𝑜𝑜𝑙𝑠 𝑜𝑓 𝑜𝑓𝑓𝑠𝑝𝑟𝑖𝑛𝑔
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Table 4: Effects of Blood Source and EIT on Fecundity, Fertility, Oviposition Time and 
Hatch Time 
Results of analysis of variance (PROC ANOVA) of effects of blood source and EIT on 
fecundity, fertility, oviposition time and hatch time. Significant values in bold type. 
 DENV-infected group Uninfected group 
Effect F 
df 
num., 
denom. 
P F 
df 
num., 
denom. 
P 
 Fecundity 
Blood source 0.769 1,7 0.383 7.596 1,7 0.007 
EIT 0.410 1,7 0.524 0.038 1,7 0.845 
Blood source*EIT 0.539 1,7 0.465 0.454 1,7 0.501 
 Fertility 
Blood source 0.030 1,7 0.863 7.089 1,7 0.009 
EIT 3.536 1,7 0.063 0.086 1,7 0.769 
Blood source*EIT 0.070 1,7 0.792 1.541 1,7 0.216 
 Oviposition time 
Blood source 13.471 1,7 0.00 0.106 1,7 0.745 
75 
 
EIT 0.230 1,7 0.633 0.636 1,7 0.427 
Blood source*EIT 0.776 1,7 0.381 1.994 1,7 0.161 
 Hatch time 
Blood source 0.067 1,7 0.797 0.701 1,7 0.404 
EIT 0.058 1,7 0.811 4.937 1,7 0.029 
Blood source*EIT 0.297 1,7 0.587 0.132 1,7 0.717 
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Table 5: Effects of Status of Infection and Blood Source on Fecundity, Fertility, Oviposition 
Time and Hatch Time 
Results of analysis of variance (PROC ANOVA) of effects of status of infection (infected or not 
infected) and blood source on fecundity, fertility, oviposition time and hatch time. Significant 
values in bold type. 
Effect F 
df 
num., 
denom. 
 
P 
 Fecundity 
Blood source 1.002 1,7 0.318 
Infection status 15.328 1,7 0.000 
Blood source*Infection status 5.594 1,7 0.019 
 Fertility 
Blood source 2.830 1,7 0.094 
Infection status 0.568 1,7 0.452 
Blood source*Infection status 3.574 1,7 0.060 
 Oviposition time 
Blood source 5.058 1,7 0.026 
Infection status 0.212 1,7 0.646 
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Blood source*Infection status 3.077 1,7 0.081 
 Hatch time 
Blood source 0.647 1,7 0.422 
Infection status 11.008 1,7 0.001 
Blood source*Infection status 0.304 1,7 0.582 
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Table 6: Effects of Blood Source and EIT on Dissemination Rate, Horizontal Transmission 
Rate, Vertical Transmission Rate, Body Titer, Leg Titer and Saliva Titer at 14 and 21 Days 
Post Infection 
Results of analysis of variance (PROC ANOVA) of effects of blood source and EIT on 
dissemination rate, horizontal transmission rate, vertical transmission rate, body titer, leg titer, 
and saliva titer at 14 and 21 days post infection. Significant values in bold type. 
 14 Days Post Infection 21 Days Post Infection 
Effect F 
df 
num., 
denom. 
P F 
df 
num., 
denom. 
P 
 Infection rate 
Blood source n/a n/a n/a n/a n/a n/a 
EIT n/a n/a n/a n/a n/a n/a 
Blood source*EIT n/a n/a n/a n/a n/a n/a 
 Dissemination rate 
Blood source 2.188 1,3 0.145 0.882 1,3 0.362 
EIT 0.088 1,3 0.768 0.882 1,3 0.362 
Blood source*EIT 0.788 1,3 0.379 0.882 1,3 0.362 
 Horizontal transmission rate 
Blood source 3.360 1,3 0.072 7.353 1,3 0.016 
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EIT 0.373 1,3 0.544 7.353 1,3 0.016 
Blood source*EIT 0.373 1,3 0.544 0.294 1,3 0.596 
 Vertical transmission rate 
Blood source n/a n/a n/a n/a n/a n/a 
EIT n/a n/a n/a n/a n/a n/a 
Blood source*EIT n/a n/a n/a n/a n/a n/a 
 Body titer 
Blood source 9.282 1,3 0.004 0.149 1,3 0.705 
EIT 0.027 1,3 0.870 0.209 1,3 0.654 
Blood source*EIT 0.098 1,3 0.756 3.427 1,3 0.084 
 Leg titer 
Blood source 0.487 1,3 0.489 0.006 1,3 0.937 
EIT 0.414 1,3 0.524 0.385 1,3 0.545 
Blood source*EIT 1.217 1,3 0.276 1.073 1,3 0.318 
 Saliva titer 
Blood source 5.570 1,3 0.000 0.246 1,3 0.641 
EIT 0.054 1,3 0.628 0.019 1,3 0.895 
80 
 
Blood source*EIT 0.239 1,3 0.316 n/a 0 n/a 
Note: Infection rate was 100% across all groups at 14 and 21 days post infection. Therefore 
statistical analysis were performed on infection rate.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 7: Chi- Square Analysis of Survival of Uninfected vs. DENV-Infected Mosquitoes 
Significant values in bold type. 
Temperature Test F df 
num., 
denom. 
P 
27°C Log Rank (Mantel-Cox) 7.86 3,4 0.049 
 Breslow (Generalized Wilcoxon) 8.11 3,4 0.044 
 Tarone-Ware 8.00 3,4 0.046 
30°C Log Rank (Mantel-Cox) 11.17 3,4 0.011 
 Breslow (Generalized Wilcoxon) 11.06 3,4 0.011 
 Tarone-Ware 11.14 3,4 0.011 
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Figure 1. Countries/Areas at Risk of Dengue Transmission 
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Figure 2. International Travel to the US from Pan American Regions 
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Figure 3. Serologically Positive Cases of Dengue Fever per Pan American Region   
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Figure 4. Incidence Rate of Dengue Infection in Pan American Regions 
  
0
0.0005
0.001
0.0015
0.002
0.0025
0.003
0.0035
0.004
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
In
ci
d
en
ce
 R
a
te
Year
North America
Central America
South America
Caribbean
86 
 
Figure 5. Potentially Infected Travellers Entering the US/Year by Pan American Region 
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Figure 6. Number of Potentially Infected Pan American Travellers Entering the US/ Year 
Note: Of the top 50 countries in the world that travel to the US, 18 are from Pan America. This graph shows those 18 countries.
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Figure 7. Infection Rate throughout Pan America/ 100,000 People in 2004 
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Figure 8. Infection Rate throughout Pan America/ 100,000 People in 2008 
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Figure 9. Infection Rate throughout Pan America/ 100,000 People in 2012 
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Figure 10. Study Design and Treatment Groups 
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Figure 11. Effect of Blood Source and EIT on Fecundity  
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Figure 12. Effect of Blood Source and EIT on Fertility 
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Figure 13. Effect of Blood Source and EIT on Oviposition Time 
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Figure 14. Effect of Blood Source and EIT on Hatch Time 
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Figure 15. Effect of Blood Source and EIT on Infection, Dissemination and Transmission at 14 Days Post Blood Feeding 
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Figure 16. Effect of Blood Source and EIT on Infection, Dissemination and Transmission at 21 Days Post Blood Feeding 
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Figure 17. Effect of Blood Source and EIT on Body, Leg and Saliva Titers at 14 Days Post Feeding 
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Figure 18. Effect of Blood Source and EIT on Body, Leg and Saliva Titers at 21 Days Post Blood Feeding 
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Figure 19. Effect of Blood Meal Source and EIT (27°C) on Survival 
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Figure 20. Effect of Blood Meal Source and EIT (30°C) on Survival 
 
